TPCB Students Ashley Chui, Sahana Rao, and Jacob Litke Win 2019 Rachele Prizes
Three TPCB students have been awarded the 2019 Julian R. Rachele Prize for their recent research publications. The prize is named for the former Dean of the Weill Cornell Graduate School and his the highest award given to students. The award recognizes publication of a significant research article in the preceding 12-month period, and is typically granted to two students each year. The recipients will present 3-minute overviews of their work at the WCGS Convocation Ceremony on May 29, 2019, and each will also receive a $500 cash prize.
TPCB students Ashley Chui (left) and Sahana Rao (center) were awarded a joint prize for their work in the lab of Prof. Daniel Bachovchin at Sloan Kettering. Their paper, “N-terminal degradation activates the NLRP1B inflammasome,” was published in the journal Science earlier this year. [Read more | Read the article in: Science]
TPCB student Jacob Litke (right) was also recognized for his research with Prof. Samie Jaffrey at Weill Cornell. His paper, “Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts,” was published in Nature Biotechnology last month. [Read more | Read the article in: Nat. Biotechnol.]
Jue Chen and Luciano Marraffini Elected to National Academy of Sciences
TPCB is pleased to announce that faculty members Prof. Jue Chen and Prof. Luciano Marraffini, both at Rockefeller, have been elected to the National Academy of Sciences. Members are elected to the Academy in recognition of their distinguished and continuing achievements in original research. Academy membership is a widely accepted mark of excellence in science and is considered one of the highest honors that a scientist can receive. With their elections, a total of nine TPCB faculty members now hold this distinction. [Read more at: Rockefeller | National Academy of Sciences]
• Prof. Jue Chen has led the use of cryo-electron microscopy to illuminate the structures and functions of ABC transporters, a family of membrane proteins that pump molecules in or out of cells. These transporters play important roles in many cellular processes, and a better understanding of their activity has broad implications for health and disease. Recent work in her lab with TPCB student Fangyu Liu has shed light on the function and regulation of the CFTR channel, whose mutation results in cystic fibrosis. Prof. Chen joined the TPCB faculty in 2015 after being recruited to Rockefeller from Purdue University. She is also named an HHMI Investigator in 2008.
• Prof. Luciano Marraffini has carried out pioneering research on CRISPR-Cas9, a bacterial immune system whose adaptation as a gene-editing tool has revolutionized biomedical science and holds promise for the prevention and treatment of many genetic diseases. He showed how this bacterial defense system cuts and destroys invading viral DNA rather than RNA, as was widely believed. Moreover, he was the first to foresee the potential application of CRISPR technology as a programmable gene-editing tool. Prof. Marraffini joined the TPCB faculty in 2012 and was named an HHMI Investigator in 2018.
TPCB Students Awarded Prestigious NSF Graduate Fellowships
The National Science Foundation (NSF) Graduate Research Fellowship is among the most prestigious and competitive fellowships awarded for graduate study. Since 1952, the program has recognized and supported outstanding graduate students in science, technology, engineering, and mathematics. TPCB is pleased to announce that current student Adi Berman and incoming student Kristen Vogt have received this honor in 2019. In addition, TPCB student Ilana Kotliar received an Honorable Mention in this year’s competition. They join five other current TPCB students who have received NSF fellowships, Natalie Jones, Michaelyn Lux, Adewola Osunsade, Nicholas Prescott, and Chaya Stern. [View the list at: NSF]
• Adi Berman was awarded a fellowship for her project entitled, “Using Chemical Proteomics to Study Biomolecular Condensation”. The project uses a chemical proteomics approach to profile key protein–protein interactions within biomolecular condensates in live cells. In particular, she will investigate the roles of these interactions in the cell cycle-dependent regulation of the cytoskeleton. Adi is currently a second-year graduate student working with Prof. Tarun Kapoor at Rockefeller.
• Kristen Vogt was recognized for her proposal entitled, “Bio-production of synthetic rubber using engineered Escherichia coli”. She is currently a senior at The College of New Jersey and will join TPCB for her graduate studies later this year. She has carried out undergraduate research in computational chemistry with Prof. Joseph Baker and served as President of TCNJ’s chapter of the Gamma Sigma Epsilon chemistry honor society.
TPCB Student Jake Litke Creates Perfect Storm for RNA Aptamer Expression
RNA (ribonucleic acid) plays a central role in translation of the genetically-encoded information in DNA to the cellular functions in proteins. In addition, RNA can fold to form secondary and tertiary structures, and this allows development of short RNA sequences called aptamers that bind specifically to proteins, metabolites, and small molecules. Because they can be genetically encoded, RNA aptamers have exciting applications as live-cell biosensors and inhibitors of cellular pathways. However, this has proven difficult to achieve in mammalian cells due to rapid degradation by exoribonucleases, which trim the ends of the RNA. To overcome this problem, TPCB student Jacob Litke and Prof. Samie Jaffrey at Weill Cornell have developed a highly efficient system for expression of circular RNAs, which are resistant to exoribonucleases. The system, called Tornado (Twister-optimized RNA for durable overexpression), leverages a self-cleaving RNA enzyme called Twister. The RNA aptamer sequence is flanked on both sides by a Twister sequence, leading to cleavage products at either end that are rapidly coupled by an endogenous RNA ligase to form the circular RNA. The system produces circular RNAs 200 times more efficiently than previous systems. The researchers showed that the Tornado system could be used to generate an RNA inhibitor of the NF-κB pathway as well as an intracellular sensor of S-adenosylmethione, a critical enzyme cofactor. The work appeared recently in Nature Biotechnology and Litke was also awarded the 2019 Julian R. Rachele Prize in recognition of his breakthrough research. [Read the article in: Nat. Biotechnol.]
Ashley Chui and Sahana Rao Elucidate Mechanism that Cells use to Combat Anthrax
Anthrax is a life-threatening bacterial infection that can be caused by exposure to infected animals and has also been used as an agent of bioterrorism. The bacteria attack the host by releasing virulence factors, one of which is a protease called lethal factor. Lethal factor cleaves and inactivates kinases in the MEK (mitogen-activated protein kinase kinase) family, which is thought to play an important role in compromising the innate immune response to infection. Conversely, lethal factor is also recognized by the innate immune system in mice and rats via its cleavage of inflammasome sensor protein NLRP1B (Nod-like receptor protein 1B; nucleotide-binding domain leucine-rich repeat pyrin domain-containing), which leads to pyroptosis, a form of programmed cell death. However, the molecular mechanism by which this proteolytic cleavage leads to inflammasome activation has remained a mystery. Now, reporting in Science, TPCB students Ashley Chui and Sahana Rao and colleagues in the laboratory of Prof. Daniel Bachovchin at MSK have elucidated this process. The team found that lethal factor cleavage of NLRP1B unveils a destabilizing N-terminal residue that activates proteasomal degradation of the autoinhibitory N-terminal fragment of the protein. This releases the C-terminal fragment, which in turn activates caspase-1, leading to pyroptotic cell death. Intriguingly, they also discovered that small-molecule inhibitors of DPP8/9 (dipeptidyl peptidases 8/9), which the team has investigated as potential anticancer agents, also activate degradation of the NLRP1B N-terminal fragment, but via a distinct pathway. This work sets the stage for further studies of both pathways to understand their roles in pathogen recognition and pyroptotic cell death. TPCB students Darren Johnson and Elizabeth Orth also contributed to the work. [Read more | Read the article in: Science]
TPCB Student Rudolf Pisa Develops Selective Inhibitors of the AAA Protein Spastin
Many dynamic cellular processes occur too rapidly to study effectively using classical biological techniques. Enter small-molecule probes, which can provide exquisite temporal control over enzyme functions to dissect their roles in such processes. However, achieving highly selective inhibition of an individual enzyme target can be challenging when there are numerous closely related targets in the cell. Now, in a pair of papers published in Nature Chemical Biology and Journal of the American Chemical Society, TPCB student Rudolf Pisa and colleagues in the laboratory of Prof. Tarun Kapoor at The Rockefeller University have developed novel, selective inhibitors of spastin. This AAA protein (ATPases associated with diverse cellular activities) severs microtubules and plays an important role in cell division and intracellular vesicle transport. There are some 100 AAA proteins that impact a wide range of cellular processes, so developing selective inhibitors is critical to their use as probes. To achieve this, the team homed in on the ATP-binding pocket of spastin and evaluated a series of known kinase inhibitors, which act by binding similarly in the ATP-binding pocket of kinases, to identify compounds that inhibit spastin selectively among a panel of three other AAA proteins. Mutagenesis of active-site residues was then used to identify potential binding interactions, which were further investigated using computational docking and molecular dynamics simulations. The team then leveraged this structural information to design spastazoline, which was a potent spastin inhibitor that did not block any of the other AAA proteins tested nor a large panel of kinases. An X-ray cocrystal structure of a spastazoline analogue bound to spastin further enabled the structure-based design of allele-specific inhibitors using a ‘bump–hole’ strategy. Finally, the team was able to use spastazoline to probe spastin function during cell division, demonstrating its utility as a new chemical probe to dissect this central cellular process. [Read more | Read the articles in: Nat. Chem. Biol. and J. Am. Chem. Soc.]
TPCB Student Wola Osunsade Develops Robust Method to Prepare H1 Linker Histones
Compaction of DNA into chromatin plays a critical role in regulating the central cellular process of DNA transcription. Nucleosome core particles, which are comprised of DNA wrapped around an octamer of histone proteins, are further consolidated by the action of H1 linker histones. To date, detailed in vitro studies of H1 histones have been precluded because their C-terminal domains contain long, unstructured, lysine-rich, degradation-prone sequences, making them extremely difficult to isolate and purify. Now, TPCB student Adewola Osunsade and colleagues in the laboratory of Prof. Yael David at MSK have developed a robust method to prepare H1 linker histones. The approach involves expressing H1 histones flanked by two orthogonal tags that promote solubility and proper folding and facilitate purification. The tags are cleaved enzymatically in a traceless fashion to provide native H1 histones. The team was able to use this approach to produce a library of H1 variants, enabling comparisons of their binding affinities to nucleosome core particles. The work provided new insights into the biochemistry of H1 proteins and sets the stage for future analyses of H1 mutations that drive disease through epigenetic modulation of gene transcription. TPCB students Nicholas Prescott, Jakob Hebert, and Devin Ray also contributed to the work, which was published in a special issue of Biochemistry entitled “The Future of Biochemistry: The International Issue”. [Read the article in: Biochemistry]
TPCB Student Zhen Chen Uncovers Molecular Mechanism of Ribosome Assembly Protein
Assembly of cellular ribosomes is a dynamic, multistep process that requires proper organization of ribosomal RNAs and proteins and is coordinated by transient interactions with a host of assembly factors. Mdn1 (midasin) is an AAA protein (ATPase Associated with various Activities) that is essential for proper removal of assembly factors from precursors of the ribosomal 60S subunit. However, Mdn1’s large size (≈5,000 amino acids) and limited homology to other proteins have made it difficult to study its molecular functions. Now, TPCB graduate student Zhen Chen, working in the lab of Prof. Tarun Kapoor at Rockefeller, has determined two cryo-EM structures of Mdn1 that shed light on its mechanism of action. The work builds upon the team’s previous discovery of the Mdn1 inhibitor, Rbin-1. The structures reveal that Mdn1’s MIDAS domain, which binds to ribosome assembly factors, is linked to the catalytic AAA domain via a flexible motif and a striking ≈20 nm structured linker. Moreover, the C-terminal MIDAS domain can dock intramolecularly with the N-terminal AAA ATPase domain in a nucleotide state trapped by the small-molecule inhibitor Rbin-1. Taken together, this study reveals that ATPase-dependent conformational changes in the AAA domain can be transmitted to the MIDAS domain, thus providing a mechanistic connection between ATP hydrolysis and ribosome assembly. This work also highlights the use of a small-molecule inhibitor to dissect the conformational dynamics of an enzyme. The study was published in Cell and carried out in collaboration with the lab of TPCB faculty member Prof. Thomas Walz. [Read more | Read the article in: Cell]
Didar Ciftci and Shixin Liu Win Prestigious Research Fellowships
TPCB is pleased to announce two recent research awards to TPCB student Didar Ciftci and TPCB faculty member Prof. Shixin Liu.
• Didar Ciftci has been awarded an American Heart Association Predoctoral Fellowship. Didar is a 4th-year student pursuing her thesis research with Prof. Olga Boudker at Weill Cornell. This two-year fellowship will support her studies of the mechanism and pharmacologic activation of neurotransmitter glutamate transporters, EAATs. These transporters maintain glutamate concentrations below excito-toxic levels by rapidly pumping the transmitter from the synaptic cleft into neuronal and glial cells in a process powered by electrochemical gradients of ions. Her studies will use a newly developed single-molecule resolution functional assay to study transporter kinetics and the effects of small-molecule probes. This work will expand our fundamental knowledge of the kinetic mechanism of the transporters and lay the foundation for future development of therapeutic EAAT activators.
• Prof. Shixin Liu at Rockefeller has received an NIH Director’s New Innovator Award. This 5-year, $2.5 million grant will support his lab’s studies of the asymmetric segregation of histones during DNA replication, which results in different chromatin states in the two daughter strands and plays a pivotal role in cell fate decisions during development and stem cell maintenance. The project aims to develop novel methodologies to probe histone inheritance in a strand-specific manner at the molecular, cellular, and systems levels using single-molecule fluorescence microscopy, super-resolution microscopy, next-generation sequencing, and quantitative mass spectrometry. This multi-pronged approach will establish a framework for characterizing the differential partitioning of histones and for understanding the role of asymmetry in driving epigenome evolution and heterogeneity of cell identity. This work will also pave the way to investigating how the dynamics of epigenetic inheritance are altered in development and disease, providing new therapeutic targets and strategies for developmental disorders, aging, and cancer. Prof. Liu is the eighth TPCB faculty member to receive this prestigious award. [Read more]
TPCB Faculty Members David Allis and Samuel Danishefsky Recognized with Major Awards
TPCB faculty member Prof. C. David Allis of The Rockefeller University has received the 2018 Lasker Award for Basic Medical Research. Widely regarded as the top prize for biomedical research in the United States, the award recognizes Prof. Allis’s seminal discovery of histone acetyltransferases, which introduce acetyl groups onto histone proteins that are associated with chromatin, thus regulating gene transcription. He shares the award with Prof. Michael Grunstein of UCLA, who earlier discovered that histone complexes called nucleosomes regulate transcription and that lysine acetylation on a histone ‘tail’ could activate gene expression. Together, these seminal studies laid the groundwork for the field of epigenetics, which has major implications today in cancer and other human diseases. [Read more at: Rockefeller | Lasker Foundation]
Prof. Samuel J. Danishefsky, TPCB Emeritus faculty member at the Memorial Sloan Kettering Cancer Center, has been awarded the Sir Derek Barton Gold Medal by the Royal Society of Chemistry. This prestigious award was established in 2001 to commemorate the life and work of Sir Derek Barton, a towering figure in the field of organic chemistry and recipient of the 1969 Nobel Prize in Chemistry. The award recognizes Prof. Danishefsky’s numerous contributions to the art of complex natural product synthesis and the development of new synthetic methods, and their applications to synthetic cancer vaccines and the total chemical synthesis of glycoproteins. Notably, the award specifically recognizes work published by Prof. Danishefsky after the age of 60, which comprises the majority of his tenure at MSK, and includes some 400 papers. This is in keeping with Sir Derek Barton’s major contributions after the mandatory retirement age in the UK, during which time he continued his career at CNRS Paris and later Texas A&M University. Prof. Danishefsky will receive the medal at a small ceremony at MSK in October. [Read more]
Tri-Institutional Chemical Biology Symposium Showcases Research Across NYC
TPCB presented the 14th Annual Tri-Institutional Chemical Biology Symposium on September 11, 2018 on the campus of The Rockefeller University. The event was attended by some 200 scientists from across the NYC area, including all three Tri-Institutional campuses, NYU, Hunter College, Queens College, the CUNY Advanced Science Research Center, Stony Brook University, and, for the first time, Bard High School Early College. Prof. Squire Booker from Penn State gave the first keynote address describing the role of iron-sulfur cluster proteins in lipoic acid biosynthesis. TPCB student Michaelyn Lux presented her work developing a palladium-catalyzed cascade reaction to synthesize bicyclic ether scaffolds in the Prof. Derek Tan’s lab. Next, Prof. Olga Boudker of Weill Cornell, also a member of the TPCB faculty, shared her latest research on the structural dynamics of glutamate transporter proteins. The morning session closed with a presentation by Jacob Litke, a TPCB student in Prof. Samie Jaffrey’s lab, on a new system for cellular expression of circular RNAs, called Tornado, for use with RNA aptamers and sensors.
Following lunch, attendees participated in a poster session with over 55 presentations from labs across the NYC area, a threefold increase over last year’s event. Awards were given in seven different categories based on judging by the keynote speakers and TPCB faculty members. In the TPCB student category, Ashley Chui and Sahana Rao, both from the lab of Prof. Daniel Bachovchin, tied for first place with their posters on activation of the Nlrp1b inflammasome, with the third place award going to Zachary Hann in the lab of Prof. Christopher Lima for his presentation on chemical probes of the ubiquitin conjugation cascade. In the TPCB early-stage student and undergraduate category, Chen Chen was awarded first prize for his presentation of his rotation project on leucine transporters with Prof. Boudker. In the final category for postdoctoral fellows and other graduate students, Dr. Eva-Maria Weick placed first for her poster describing her work on the cryo-EM structure of the human RNA exosome–MTR4 complex with Prof. Lima. NYU student Daniel Yoo received the second place award for his presentation on covalent α-helical inhibitors of Ras mutants with Prof. Paramjit Arora. The third place award went to Dr. Sahil Sharma in the lab of TPCB faculty member Prof. Gabriela Chiosis, for his poster on purine-based inhibitors of Grp94, an endoplasmic reticulum Hsp90 paralog. The winners received journal subscription awards generously provided by Cell Chemical Biology, Nature Chemical Biology, and the Royal Society of Chemistry.
Prof. Nieng Yan of Princeton University kicked off the afternoon session with a keynote address on the structures of voltage-gated sodium channels, graciously presenting by Skype from China in the middle of the night as she was unable to attend the symposium in person. TPCB student Fangyu Liu from the lab of Prof. Jue Chen then presented structural insights into the gating mechanism of the CFTR chloride ion channel that is mutated in cystic fibrosis patients. The final keynote presentation of the day was given by Prof. Ronald Raines of MIT, who shared his lab’s latest work leveraging the reactivity of α-diazoketones to label small molecules and proteins. The symposium concluded with a reception for the participants, who continued to discuss the wide range of chemical biology research shared throughout the day.
TPCB received generous support once again this year from its promotional partners, ACS Chemical Biology, Biochemistry, Cell Chemical Biology, Chemical Science, Chemical Society Reviews, Nature Chemical Biology, Organic & Biomolecular Chemistry, and the New York Academy of Sciences. The event was organized by TPCB students Mizuho Horioka, Lin Mei, and Sahana Rao, with guidance from TPCB faculty member Prof. Daniel Heller. [Read more at Chem. Sci.]
Annual TPCB Student Retreat Held at Mohonk Mountain House
The 2018 TPCB Student Retreat was held on August 7–8, 2018 at Mohonk Mountain House in New Paltz, New York. The retreat was held jointly this year with the Tri-I Computational Biology & Medicine (CBM) PhD program. TPCB and CBM students based at Weill Cornell, Sloan Kettering, Rockefeller University, and Cornell Ithaca were brought together to enjoy two days of networking, scientific development, and relaxation. The Retreat featured three-minute thesis talks by students, career development sessions led by TPCB alumni, and a grantwriting workshop presented by Dr. Ushma Neill, Vice President of Scientific Education & Training at MSK. TPCB alumni Jayakrishnan Nandakumar, PhD (’07, Assistant Professor, University of Michigan) and Nikhil Singla, PhD (’10, Director, Program Management, International AIDS Vaccine Initiative) offered their insights about their respective careers in academia and industrial science. Students also enjoyed social activities including karaoke, trivia, hiking, boating, swimming, and exploring the beautiful Mohonk Mountain House property. The event was organized by TPCB students Jake Hebert and Wola Osunsade, both in the lab of Prof. Yael David at MSK, and was supported by the TPCB NIH T32 Chemistry–Biology Interface Training Grant.
ChBSP Students Present their Summer Research
The Chemical Biology Summer Program (ChBSP) launched this year with an outstanding class of six undergraduate students who spent their summers pursuing forefront chemical biology research in TPCB labs. The students also participated in a wide range of scientific and career development activities with students from other summer undergraduate research programs hosted at MSK. The program culminated with a poster session on August 9, 2018, which was attended by over a hundred scientists from across the Tri-Institutional campuses.
ChBSP Program Director Prof. Daniel Bachovchin commented, “The students accomplished an extraordinary amount of research over the summer, and communicated their findings clearly and thoughtfully at today’s poster session. I could not be more impressed!” ChBSP received generous financial support from the Sanders Innovation & Education Initiative of the Tri-Institutional Therapeutics Discovery Institute (TDI). Dr. Peter Meinke, CEO of TDI, noted, “We recognize programs like ChBSP as key components of the Sanders Innovation and Education Initiative. It is critical that we provide world-class educational opportunities to young scientists, to inspire future generations to aspire to scientific leadership and innovation in new drug discovery and development. The success of this year’s program is a credit to the organizers and an effort that TDI anticipates continuing to support.”
• Angelina Grebe (Fordham University), Progress towards Structural Characterization of Muramyl Dipeptide–NOD2 Complex (with Prof. Howard Hang, Rockefeller)
• Nathan Harper (Lafayette College), Biochemical Analysis of Mdn1, an AAA Protein Required for Ribosome Biogenesis (with Prof. Tarun Kapoor, Rockefeller)
• Sophie Kong (Bucknell University), Initiation of Caspase-1-Dependent Pyroptosis by Activator CARD Domains (with Prof. Daniel Bachovchin, MSK)
• Maham Mahmood (Adelphi University), Screening Modulators that Stabilize the PRMT5–MTA Complex against MTAP/CDKN2A-deleted Cancer Cells (with Prof. Minkui Luo, MSK)
• Rashmi Rao (Cornell University), Structure-Dependent Fluorescence Properties of a Novel Flurogenic Aptamer Derived from Adenine Riboswitch (with Prof. Samie Jaffrey, Weill Cornell)
• Lauren Vostal (Williams College), HIBCH Inhibition in Oncogenic KRAS-drived Pancreatic Ductal Adenocarcinoma (with Prof. John Blenis, Weill Cornell)
TPCB Student Darren Johnson Elucidates Mechanism of Anticancer Drug
Acute myeloid leukemia (AML) is an aggressive cancer that involves rapid growth of abnormal cells in the bone marrow and blood, interfering with normal development and function of blood cells. Now a team of researchers led by TPCB student Darren Johnson in the lab of Prof. Daniel Bachovchin at MSK has shown that the anticancer drug Val-boroPro (tabalostat) provides a promising new lead for treating AML. Reporting in Nature Medicine, the team found that Val-boroPro, which they have shown previously targets the serine dipeptidases DPP8 and DPP9, has cytotoxicity against both AML cell lines and primary AML cells. They discovered that Val-boroPro activates the protein CARD8, leading to a pro-caspase-1 dependent form of cell death called pyroptosis. Building on these results, they demonstrated in vivo anticancer efficacy of Val-boroPro in mouse models of AML. This work sets the stage for further exploration of DPP8/9 inhibitors as new therapeutics to treat AML. TPCB students Ashley Chui and Sahana Rao, and TPCB faculty member Prof. Alex Kentsis, also contributed to the work. [Read more | Read the article in: [Nat. Med.]
TPCB Congratulates Our 2018 Graduates
Congratulations to the TPCB’s 2018 graduates Malik Chaker-Margot (Klinge Lab, Rockefeller), Adam Trotta (Danishefsky Lab, MSK), and John Zinder (Lima Lab, MSK). Our graduates were recognized at a TPCB luncheon on June 21, 2018. They received their degrees at the Weill Cornell Graduate School graduation ceremony on May 31, 2018 at Carnegie Hall and at The Rockefeller University Convocation Ceremony on June 14, 2018. Students in MSK labs were also recognized at the Gerstner Sloan Kettering Commencement Ceremony on June 1, 2018.
• Malik Chaker-Margot, PhD – “Making Ribosomes: Biochemical and Structural Studies of Early Ribosomes in Yeast”
Current position: Postdoctoral Fellow, Prof. Timm Maier, Biozentrum, University of Basel
• Adam Trotta, PhD – “Towards the Total Synthesis of the Oridamycin and Xiamycin Family of Indolosesquiterpenes”
Current position: Postdoctoral Fellow, Prof. Eric Jacobsen, Harvard University
• John Zinder, PhD – “Structure and Activities of the Saccharomyces cerevisiae Nuclear RNA Exosome”
Current position: Postdoctoral Fellow, Prof. Titia de Lange, The Rockefeller University
Luciano Marraffini Named HHMI Investigator
TPCB faculty member Prof. Luciano Marraffini of The Rockefeller University has been named a Howard Hughes Medical Institute Investigator. He is one of 19 new HHMI Investigators selected from a pool of 675 applicants for a seven-year term, receiving approximately $8 million in funding. Prof. Marraffini’s lab has performed pioneering studies on how bacteria and archaea defend themselves against viruses. In what has turned out to be a discovery with a remarkably broad array of possible uses, they revealed how a bacterial defense system, CRISPR-Cas, cuts and destroys invading viral DNA rather than RNA strands, as was originally predicted. In collaboration with colleagues at the Broad Institute, Prof. Marraffini reported the first successful genome-editing project based on CRISPR-Cas, technology that has now received significant attention for its potential applications in science and medicine. He joins TPCB’s other five HHMI investigators: Olga Boudker, Jue Chen, Christopher Lima, Roderick MacKinnon, and Nikola Pavletich. [Read more at: Rockefeller | HHMI]
TPCB Students and Faculty Recognized with Prestigious Fellowships and Awards
TPCB students and faculty have received numerous fellowships and awards in recognition of their research programs in chemical biology. Recently, TPCB student Chaya Stern and faculty members Prof. Daniel Bachovchin and Prof. Stewart Shuman were honored.
• Chaya Stern, a 5th year student in the laboratory of Prof. John Chodera at MSK, has been awarded a fellowship from the Molecular Sciences Software Institute to support her work in developing new computational chemistry software. Her project aims to improve the accuracy and quantify the uncertainty of molecular mechanics force fields by generating a database of chemically accurate quantum mechanics data, automating torsion parameter fitting, and propagating force field uncertainties to predictions. The fully open-source software is being designed for the molecular simulation community and is part of the Open Forcefield Initiative. [Read more at: MolSSI]
• Prof. Daniel Bachovchin at MSK has been recognized with two prestigious fellowships for junior faculty. He was one of seven scientists to receive the Pershing Square Sohn Prize for Young Investigators in Cancer Research. His project aims to develop a highly innovative chemical-proteomics platform to determine the mechanism of action of anti-cancer protease inhibitors. He is the second TPCB faculty member to receive this honor, following Prof. Daniel Heller who was recognized last year. In addition, Prof. Bachovchin has been named a 2018 Sloan Research Fellow in Chemistry. This award recognizes his work in chemical biology as one of the most promising early-career scientists in the U.S. and Canada. Four other TPCB faculty have received this distinction previously: Prof. Sebastian Klinge (2014), Prof. Vanessa Ruta (2013), Prof. Derek Tan (2007), and Prof. Timothy Ryan (1999). [Read more at: Pershing Square Sohn | Alfred P. Sloan Foundation]
• Prof. Stewart Shuman at MSK has received an NIH Maximizing Investigators’ Research (MIRA) Award. These extended, 5-year grants were established by the National Institute of General Medical Sciences (NIGMS) in 2015 to provide investigators with greater funding stability and scientfiic flexibility, enhancing the chances for important breakthroughs. Prof. Shuman’s long-standing and highly-accomplished research program seeks to illuminate fundamental DNA and RNA transactions at a molecular level. His lab studies the mechanisms, structures, and regulation of enzymes that perform nucleic acid synthesis, modification, and repair. Current targets include polynucleotide ligases, mRNA capping enzymes, tRNA splicing enzymes, ribotoxin, and the RNA polymerase II C-terminal domain. He is the fifth TPCB faculty member to receive NIGMS MIRA support, joining Prof. Sean Brady, Prof. Seth Darst, Prof. Joshua Levitz (Early-Stage Investigator Award), and , Prof. Christopher Lima.
TPCB’s Chemical Biology Summer Program Welcomes Inaugural Class
TPCB is pleased to welcome the inaugural class of undergraduate summer interns to the new Chemical Biology Summer Program (ChBSP)! This 10-week program gives undergraduate students the opportunity to pursue forefront research in chemical biology in TPCB labs, working alongside our graduate students and faculty. ChBSP students also attend scientific lectures and professional development seminars as part of their summer experience. The program will culminate with a poster session on Thursday, August 9th, showcasing summer undergraduate research from across the Tri-Institutional campuses. [Read more]
This year’s ChBSP summer interns are:
- • Angelina Grebe, Fordham University, Class of 2019, Chemistry (with Prof. Howard Hang, Rockefeller)
- • Nathan Harper, Lafayette College, Class of 2019, Biology (with Prof. Tarun Kapoor, Rockefeller)
- • Sophie Kong, Bucknell University, Class of 2019, Biochemistry (with Prof. Daniel Bachovchin, MSK)
- • Maham Mahmood, Adelphi University, Class of 2019, Biochemistry (with Minkui Luo, MSK)
- • Rashmi Rao, Cornell University, Class of 2020, Chemistry (with Prof. Samie Jaffrey, Weill Cornell)
- • Lauren Vostal, Williams College, Class of 2019, Chemistry (with Prof. John Blenis, Weill Cornell)
TPCB Research Features at NYAS 2018 Chemical Biology Symposium
The New York Academy of Sciences (NYAS) annual year-end Chemical Biology Symposium, presented in partnership with TPCB, is a highlight for chemical biologists across the tristate area, bringing together undergraduates, graduate students, postdocs, faculty, and staff scientists from numerous major academic institutions and pharmaceutical companies. This year’s event was held on May 23, 2018 and featured a keynote presentation by Prof. Joanne Stubbe of MIT. Prof. Stubbe described her long-standing research program on the structure and function of ribonucleotide reductase, with recent efforts focusing on elucidating striking conformational changes that regulate long-range, proton-coupled electron transfer from an iron center to the ribonucleotide substrate. Students and postdocs from TPCB labs were well-represented in the poster session, and several were selected for oral presentations, including TPCB student Jacob Litke, who presented his work with Prof. Samie Jaffrey at Weill Cornell on developing a platform for efficient expression of circular RNA sensors; postdoctoral fellow Dr. Cornelius Taabazuing of Prof. Dan Bachovchin’s lab at MSK, who described his discovery of crosstalk between pyroptotic and apoptotic signaling pathways, and recent graduate, Dr. Zhenrun (Jerry) Zhang of Prof. Howard Hang’s lab at Rockefeller, who discussed the role of short-chain fatty acids in Salmonella virulence. In addition, TPCB student Michaelyn Lux, from Prof. Derek Tan’s lab at MSK, was awarded one of three F1000 poster prizes for her presentation on the development of a new palladium cascade reaction to generate fused bicyclic ethers. [Read more]
TPCB Student Sahana Rao Uncovers Mechanism of Novel Anticancer Agent
Val-boroPro is a small molecule that triggers a form of programmed cell death called pyroptosis in certain cell types and induces immune-mediated tumor regression in mouse models of cancer. Now, reporting in Cell Chemical Biology, TPCB student Sahana Rao and coworkers in the laboratory of Prof. Daniel Bachovchin at Sloan Kettering present new insights into the mechanism of pyroptosis induction. Previous work in the Bachovchin lab demonstrated that Val-boroPro acts by inhibiting the dipeptidyl peptidases DPP8 and DPP9, but the mechanism by which this induces pyroptotic cell death was unknown. Using Val-boroPro as a chemical probe, they now show that this inhibition activates the Nlrp1b inflammasome, a protein complex that promotes cellular inflammatory responses leading to cytokine secretion and cell death via pyroptosis. TPCB students Ashley Chui and Darren Johnson in the Bachovchin lab also contributed. This study reveals a new mechanism for activation of the innate immune response and suggests a role for DPP8/9 in regulation of the innate immune system. [Read the article in: Cell Chem. Biol.]
TPCB Student Linamarie Miller Elucidates Maturation of Ribosome Large Subunit
The ribosome is built from proteins and ribosomal RNAs that are assembled and folded in a complex, multistage process. In a new report in Nature, TPCB student Linamarie Miller and colleagues in the laboratory of Prof. Sebastian Klinge at Rockefeller describe the cryo-EM structures of the nucleolar pre-60S ribosomal subunit in three different conformational states. Some 21 ribosome assembly factors work together to stabilize and remodel the rRNA and protein constituents. The work was performed in collaboration with the lab of TPCB faculty member Prof. Brian Chait, also at Rockefeller, who carried out cross-linking and mass spectrometry studies to help characterize the architecture of the assembly factors. TPCB student Malik Chaker-Margot in the Klinge lab also contributed. This work provides new insights into the molecular mechanisms that drive ribosome assembly forward in a unidirectional manner. [Read more | Read the article in: Nature]
TPCB Alumni Launch Independent Research Programs
Graduate training in TPCB prepares students for a wide range of scientific careers. Among our alumni are 9 tenure-track faculty, including Doeke Hekstra, Rashad Karimov, Sumana Sanyal, and Qian Yin who recently launched their independent labs:
• Doeke Hekstra, PhD (Assistant Professor, Department of Molecular & Cellular Biology, Harvard University) studies the mechanics of biomolecules, and more generally the role of physical and evolutionary forces in shaping biological systems. [Read more]
• Rashad Karimov, PhD (Assistant Professor, Department of Chemistry & Biochemistry, Auburn University) develops new methodologies for the synthesis of saturated nitrogen heterocycles, involving dearomatization of nitrogen heteroaromatics and new hetero-cycloaddition and annulation reactions. [Read more]
• Sumana Sanyal, PhD (Assistant Professor, Division of Public Health Laboratory Sciences, Pasteur Research Pole, The University of Hong Kong) focuses on understanding the role of ubiquitin and ubiquitin-like modifiers in host–pathogen interactions that orchestrate an outcome between successful viral infection versus host restriction. [Read more]
• Qian Yin, PhD (Assistant Professor, Department of Biological Science, Florida State University) studies the function of IFN-inducible GTPases and their activation and regulatory mechanisms in inflammation, autophagy, and host–pathogen interactions using biochemical, structural, cellular, and pharmacological approaches. [Read more]
TPCB Launches Summer Undergraduate Internship Program
TPCB is excited to announce the launch of a new Chemical Biology Summer Program (ChBSP) for undergraduates in the New York City area. This 10-week program will launch in the summer of 2018, giving students the opportunity to perform cutting-edge research in chemical biology in the laboratory of a TPCB faculty member. Students will work alongside graduate students and postdocs in the labs and will also attend weekly research seminars presented by the faculty and workshops on professional and career development. Students will present their research in a poster session at the end of the summer, alongside students from a broad range of other summer programs hosted on the Tri-Institutional campuses.
The program is directed by TPCB faculty member Prof. Daniel Bachovchin at Sloan Kettering and is receiving generous financial support from the Sanders Educational Initiative of the Tri-Institutional Therapeutics Discovery Institute and organizational support from the MSK Office of Education and Training. Students will receive a $4,000 stipend. However, no housing is provided, so the program is geared toward students who already have local accommodations in the NYC area. US citizenship or permanent residency is required. Online applications are open from November 1, 2017 to February 2, 2018. [Read more]
TPCB Presents the 13th Annual Tri-Institutional Chemical Biology Symposium
The 13th Annual Chemical Biology Symposium, presented by TPCB, was held on September 7, 2017 at MSK. Organized by TPCB students Ashley Chui, Rachel Leicher, and Linamarie Miller, the event was attended by over 150 scientists from across the greater NYC area. The day started with a faculty keynote lecture by Prof. Helen Blackwell from the University of Wisconsin–Madison, who presented her lab’s work on small-molecule probes of bacterial quorum sensing systems. TPCB student John Zinder shared his research on characterizing the structure and function of the RNA exosome in the lab of Prof. Christopher Lima at MSK. TPCB faculty member Prof. Daniel Heller gave the second keynote lecture on nanochemical biology approaches to drug delivery and molecular imaging. The morning session concluded with a talk by TPCB student Shi Chen, who described his work on the conformational dynamics of the protein lysine methyltransferase SET8, carried out in the lab of Prof. Minkui Luo in collaboration with TPCB student Rafal Wiewora in the lab of Prof. John Chodera at MSK.
Symposium participants were then treated to lunch and a poster session highlighting recent advances in chemical biology research across the Tri-Institutional Research Program. Poster prizes were awarded to TPCB students Rudolph Pisa (Kapoor Lab, RU), Darren Johnson (Bachovchin Lab, MSK), and Michaelyn Lux (Tan Lab, MSK) and postdoctoral fellow Nathan Westcott (Hang Lab, RU). Journal subscription awards were generously sponsored by the Royal Society of Chemistry, Cell Chemical Biology, and Nature Chemical Biology, and the winners also received gift cards from TPCB.
In the afternoon session, Prof. Dorothee Kern of Brandeis University gave an engaging and music-filled presentation on her lab’s studies of the evolution of enzyme catalysis and regulation. TPCB student Zhen Chen then shared his research in the lab of Prof. Tarun Kapoor at RU on the discovery of novel ribosome biogenesis inhibitors that target the AAA protein Mdn1. Prof. Kevan Shokat of UCSF gave the final keynote presentation on his lab’s recent progress developing novel small-molecule inhibitors of mTOR and KRas for cancer therapy. The event concluded with a reception at which participants continued to discuss the latest advances in the field over food and drinks.
TPCB received generous support for the event from our promotional partners, ACS Chemical Biology, Biochemistry, Cell Chemical Biology, Chemical Science, Chemical Society Reviews, Nature Chemical Biology, Organic & Biomolecular Chemistry, and the New York Academy of Sciences. [Read more at Org. Biomol. Chem.]
Students Share Research and Get Career Advice from Alumni at 2017 TPCB Retreat
The 2017 TPCB Student Retreat was held on August 14-15, 2017 at Mohonk Mountain House, New Paltz, NY. The event brought all TPCB students based at Weill Cornell, Sloan Kettering and Rockefeller University together for the summer. The retreat featured research talks by students in the form of three-minute thesis presentations and career development talks led by TPCB alumni. Students enjoyed various social activities from karaoke, hiking, boating, swimming and just exploring the beautiful Mohonk Mountain House property. Students appreciated hearing from alumni who offered useful insights about their respective careers in academia, administration and big pharma. Alumni guests included Disan Davis, PhD, (Program Manager, Science Outreach, Rockefeller University), Jarrod French, PhD, (Assistant Professor, Department of Biochemistry & Cell Biology, Stony Brook University), and Adam Levinson, PhD, (Research Scientist, Eli Lilly & Company).
The event was organized by TPCB students Ashley Chui (Bachovchin Lab, Sloan Kettering), Rachel Leicher (Liu Lab, Rockefeller), and Linamarie Miller (Klinge Lab, Rockefeller), and supported by the TPCB NIH T32 Chemistry-Biology Interface Training Grant.
TPCB Student Fangyu Liu Determines Structures of Human Protein that Causes Cystic Fibrosis
Cystic fibrosis arises from mutations in a single gene, CFTR (cystic fibrosis transmembrane conductance regulator), which encodes a chloride ion channel. Dysfunction of CFTR leads to accumulation of mucus in the lungs that can cause potentially fatal breathing problems and respiratory infections. In a recent Cell article, TPCB student Fangyu Liu and colleagues in the laboratory of Prof. Jue Chen at Rockefeller have reported the first molecular structure of the human CFTR protein using cryo-EM. This builds upon previous work in the lab determining the structure of CFTR from zebrafish, and reveals a previously unresolved helix in the R domain that that precludes channel opening. CFTR channel gating is strictly coupled to phosphorylation and ATP hydrolysis, and this study presented the channel in its dephosphorylated, ATP-free form. Electrophysiology experiments suggested that activation of the CFTR channel by R domain phosphorylation is enabled by infrequent, spontaneous disengagement of the R domain from the channel. Subsequently, in a second Cell paper, the team determined the structure of CFTR in its phosphorylated, ATP-bound conformation, in which major structural rearrangements lead to R domain disengagement and channel opening. Together, these reports provide new insights into the molecular mechanism of CFTR function and may ultimately inform the development of new therapeutics for cystic fibrosis to restore proper function of CFTR mutants. [Read more | Read the articles in: Cell (23 Mar 2017) and Cell (27 Jul 2017)]
TPCB Congratulates Our 2017 Graduates
Congratulations to the TPCB’s 2017 graduates Angelica Ferguson (Blanchard Lab, Weill Cornell), Adam Levinson (Danishefsky Lab, Sloan Kettering) and Carlos Rico (Sakmar Lab, Rockefeller). Our graduates received their degrees at the Weill Cornell Graduate School of Medical Sciences graduation ceremony on June 1, 2017 at Carnegie Hall. Students in Sloan Kettering labs were also recognized at the Gerstner Sloan Kettering Commencement Ceremony on May 18, 2017. Students in Rockefeller labs were recognized at The Rockefeller University Commencement Ceremony on June 15, 2017.
• Angelica Ferguson, PhD – “Functional Dynamics of the Human Ribosome Revealed by smFRET and Single-Particle cryoEM”
• Adam Levinson, PhD – “Part I: Total Synthesis of Aspeverin and Penicimutamide A; Part II: Total Chemical Synthesis and Folding of All-L and All-D KRas(G12V) and the Further Exploration of Isonitrile-Mediated Peptide Ligations”, Research Scientist, Eli Lilly & Company
• Carlos Rico, PhD – “Single-molecule Ligand Binding Studies on CCR5 by Fluorescence Cross-correlation Spectroscopy”, Postdoctoral Fellow, Prof. Thomas Sakmar, The Rockefeller University
Gregory Alushin, Joshua Levitz, Simon Scheuring, Thomas Walz, and Harel Weinstein Join the TPCB Faculty
TPCB recently welcomed two new junior and three new senior faculty members to the graduate program, bringing diverse research interests in the molecular mechanisms behind cytoskeletal rearrangement and membrane protein function:
• Prof. Gregory Alushin of Rockefeller studies the role of actin plasticity on the ability of cells to sense and respond to the mechanical properties of their surroundings. His lab uses molecular engineering to probe the forces involved in protein conformational changes. He received his PhD in 2012 from the University of California, Berkeley, under the guidance of Prof. Eva Nogales. After a brief postdoc with Dr. Clare Waterman at NHLBI, he received a prestigious NIH Director’s Early Independence Award and established his independent lab. Prof. Alushin joined TPCB and the Rockefeller faculty in January 2017. [Read more]
• Prof. Joshua Levitz of Weill Cornell uses high-resolution chemical and optical methods to study dynamic molecular processes involved in neurological signaling. His lab develops chemical optogenetic tools and single-molecule fluorescence-based assays to elucidate these fundamental processes. He carried out his PhD studies with Prof. Ehud Isacoff at the University of California, Berkeley, graduating in 2014. He then carried out postdoctoral training with Prof. Mu-ming Poo and Ehud Isacoff until 2016, when he joined TPCB and the Weill Cornell faculty. [Read more]
• Prof. Simon Scheuring of Weill Cornell is a leader in the use of atomic force microscopy to study the structure, dynamics, diffusion, interaction, mechanics, and supramolecular assembly of membrane proteins and other membrane constituents. He carried out his Diploma, PhD, and postdoctoral studies at the Biozentrum of the University of Basel in Switzerland. He was most recently a Senior Research Director in INSERM at Aix-Marseille Université in France. He joined TPCB and the Weill Cornell faculty in early 2017. [Read more]
• Prof. Thomas Walz of Rockefeller is interested in processes that involve biological membranes, particularly how lipids affect the structure and function of membrane proteins, and uses electron microscopy techniques to gain an atomic level understanding of these processes. He took his Diploma and PhD at the Biozentrum of the University of Basel in Switzerland, then went onto postdoctoral studies at the Krebs Institute at the University of Shefield in the UK. He was most recently a Professor and HHMI Investigator at Harvard Medical School in the Department of Cell Biology. He joined Rockefeller in 2015 and was appointed to the TPCB faculty in early 2017. [Read more]
• Prof. Harel Weinstein of Weill Cornell is a leader in computational chemistry and computational biophysics. His research uses computational modeling and simulation to understand the structural and dynamic mechanisms of cellular components. He completed his BSc, MSc, and DSc at Technion – Israel Institute of Technology and began his independent career at the Mount Sinai School of Medicine. He joined Weill Cornell as Professor and Chairman of the Department of Physiology and Biophysics in 2002 and was appointed to the TPCB faculty in early 2017. [Read more]
Daniel Bachovchin Receives Two Junior Faculty Awards
Prof. Daniel Bachovchin at Sloan Kettering has been named a 2017 Pew-Stewart Scholar in Cancer Research and has also been awarded a Stand Up To Cancer (SU2C) Innovative Research Grant. The Pew-Stewart Scholarship is a four-year award is funded by the Alexander and Margaret Stewart Trust and administered by the Pew Charitable Trusts to support promising early career scientists whose research will accelerate discovery and advance progress to a cure for cancer. The SU2C Innovative Research Grant program provides three years of support for cutting-edge cancer research by early-career scientists with novel, high-risk, high-impact ideas. Prof. Bachovchin’s research focuses on characterizing the functions of enzymes in normal and pathological processes, particularly the roles of serine proteases in cancer and immune system signaling. They use a variety of tools and approaches, including new chemical probes developed in the lab, mass spectrometry-based proteomics, activity-based protein profiling, and genome engineering (CRISPR). He is the first TPCB faculty member to receive each of these honors. [Read more at: Pew-Stewart Scholars | Stand Up To Cancer]
TPCB Student Adam Levinson Targets “Undruggable” Target
The oncoprotein KRas acts as a switch that drives cellular growth and survival. Mutations in KRas are linked to nearly 30% of all cancers, making it an attractive target for cancer therapy. However, KRas has long been considered an “undruggable” target, in large part because it binds extremely tightly to its natural substrate GTP. As a result, traditional drug discovery approaches have failed to discover effective KRas inhibitors. In a new paper in J. Am. Chem. Soc., recent TPCB graduate Adam Levinson and colleagues in the lab of Prof. Samuel Danishefsky at Sloan Kettering and Prof. Gregory Verdine at Harvard report an innovative approach to tackling this challenge, leveraging fundamental concepts in stereochemistry. Using yeast display, massive libraries of L-peptides are presented on the cell surface and can be selected for binding to the target of interest, enabling directed evolution to identify potent ligands. However, because L-peptides are readily degraded by proteases, they generally do not make effective drugs without modifications to evade this process. Thus, in the mirror-image approach, the D-enantiomer of the target is instead used in the screen. The L-peptide ligands that are discovered are then synthesized chemically as their D-peptide enantiomers, which analogously bind the original L-protein target. Importantly, these D-peptide ligands are not subject to proteolysis, and serve as attractive starting points for further drug development efforts. To enable this approach, the team executed the total chemical synthesis of the D-enantiomer of entire KRas protein in the lab, using native chemical ligation as well as related peptide ligation strategies developed in the Danishefsky lab over the last decade. They subsequently showed that this mirror-image protein folded properly and bound to the corresponding unnatural enantiomer of a non-hydrolyzable GTP analogue. This tour de force in chemical synthesis now sets the stage for screening efforts to discover novel KRas inhibitors based on D-peptides. [Read more | Read the article in: J. Am. Chem. Soc.]
NYAS 2017 Chemical Biology Symposium Brings Together NYC Scientists
The New York Academy of Sciences (NYAS) held its annual year-end Chemical Biology Symposium on May 24, 2017, in partnership with TPCB. This annual meeting brings together chemical biology researchers from universities and pharmaceutical companies across the tristate area and is a highlight of the NYAS Chemical Biology Discussion Group’s annual symposium series. This year’s event featured two keynote speakers, TPCB faculty member Prof. Sean Brady of Rockefeller as well as Prof. Dirk Trauner, who recently relocated his lab to NYU. Prof. Brady presented his lab’s recent discovery of humimycin as a novel antibiotic active against methicillin-resistant Staphylococcus aureus infections. The compound was discovered using bioinformatic analysis of genomes from human gut bacteria. Prof. Trauner shared his lab’s efforts to develop photopharmacology tools to provide precise control over protein function, with potential applications in vision restoration. Students and postdocs from TPCB labs as well as other labs across the NYC area presented posters on their research. Several were selected for oral presentations, including one by Dr. Corinne Foley from the lab of TPCB faculty member Prof. Derek Tan, who discussed the discovery of novel antitrypanosomal alkaloids from a diversity-oriented synthesis library. Several poster prizes were also awarded, including one to Dr. Maria Chiriac, also from the Tan lab, who described her work on developing novel macrocyclic inhibitors of bacterial adenylation enzymes. The event was co-organized by TPCB faculty member Prof. Howard Hang of Rockefeller. [Read more]
Morgan Huse Receives Boyer Young Investigator Award
Prof. Morgan Huse at Sloan Kettering has been honored with the Louise and Alston Boyer Young Investigator Award for Excellence in Basic Research, which recognizes outstanding junior faculty at MSK. Prof. Huse’s lab combines imaging technology with synthetic chemistry and materials science to understand how immune cells communicate. He joins several other TPCB faculty members who received this honor in recent years: Christopher Lima (2006), Stephen Long (2016), Derek Tan and (2010). [Read more]
Christopher Lima Elected Fellow of the American Academy of Arts and Sciences
Prof. Christopher Lima at Sloan Kettering has been named a Fellow of the American Academy of Arts and Sciences. Election to the Academy is one of the most significant honors one can receive and recognizes leadership in addressing critical challenges facing society. Prof. Lima’s lab uses structural, biochemical, and functional approaches to study molecules involved in RNA processing and protein modification. His lab investigates on how ubiquitin and the related protein SUMO are attached to other proteins to modify their function or fate. His lab also focuses on systems that contribute to RNA stability and degradation. He is the seventh TPCB faculty member to named a Fellow, joining C. David Allis (2001), Lewis Cantley (1999), Samuel Danishefsky (1984), Dinshaw Patel (2014), Nikola Pavletich (2014), and Stewart Shuman (2015). [Read more]
TPCB Students Mehtap Isik and Rafal Wiewora Awarded Prestigious Fellowships
Two TPCB students have been awarded prestigious fellowships to support their graduate research!
Mehtap Isik has received the 2017 Hutchinson Fellowship from the Sloan Kettering Division of the Weill Cornell Graduate School of Medical Sciences. The award is named after Dr. Dorris J. Hutchinson, who was a microbiologist in the Sloan Kettering Institute for nearly 40 years studying new treatments for tuberculosis and leukemia. Dr. Hutschinson was also instrumental in establishing the Sloan Kettering Division of the Weill Cornell Graduate School and this award supports outstanding students pursuing their thesis research in this program at Sloan Kettering. Mehtap’s project focuses on the development of model protein–ligand systems to advance the field of predictive quantitative computational modeling for drug discovery. Her project uses a combination of robotic wetlab experiments and advanced GPU computing. She carried out her undergraduate training at Boğaziçi University in Turkey. [Read more]
Rafal Wiewiora has been awarded a Horizon Award by the Department of Defense’s Peer Reviewed Cancer Research Program. This two-year grant supports exceptional junior-level scientists pursuing research in cancer with the guidance of a faculty mentor. Rafal’s project investigates the conformational heterogeneity of histone methyltransferases using molecular dynamics simulations on the Folding@home platform, a worldwide distributed computing project where hundreds of thousands of people around the world contribute their computing power toward the understanding of cancer targets. These models of conformational dynamics will be vital in aiding the in silico design of selective chemical probes to understand the roles that these methyltransferases play in cancer, as well as to develop new strategies to inhibit them. A native of Poland, Rafal received his MChem degree from the University of Oxford. [Read more]
Both Mehtap and Rafal are third-year TPCB students working in the lab of Prof. John Chodera at Sloan Kettering.
Gregory Alushin Receives Presidental Early Career Award for Scientists and Engineers
Prof. Gregory Alushin at Rockefeller has a Presidential Early Career Award for Scientists and Engineers. Established in 1996, this award represents the highest honor given by the U.S. government to science and engineering professionals in the early stage of their careers. Prof. Alushin’s lab studies how cells use their structural filaments to sense and respond to mechanical forces. Using cryo-electron microscopy along with biochemical and biophysical approaches, his lab aims to understand how changes to actin—a predominant class of protein filaments—are linked to alterations in gene expression in development and disease. He is the first TPCB faculty member to receive this honor. [Read more at Rockefeller | Office of the White House Press Secretary | NIH]
TPCB Student Malik Chaker-Margot Solves Structure of Key Intermediate in Ribosome Assembly
The assembly of eukaryotic ribosomes, the cell’s protein-synthesizing factories, is a complicated process that is not yet fully understood. This is partly because the enormous size and complexity of the eukaryotic ribosomal machinery complicate efforts to obtain atomic-level structural information for key intermediates. Now, in a breakthrough study reported in Science, TPCB student Malik Chaker-Margot and colleagues in the lab of Prof. Sebastian Klinge at Rockefeller, report the 5.1 Å cryo-electron microscopy (cryo-EM) structure of an important intermediate in ribosome assembly, called the small subunit (SSU) processome. The yeast SSU processome is a giant ribonucleoprotein particle, composed of approximately 70 proteins and several RNAs, that is involved in the assembly of the small eukaryotic ribosomal subunit. By examining the cryo-EM structure, the team gained important insights that led them to develop a new model for SSU processome assembly, in which an RNA leader sequence participates during the maturation of the small ribosomal subunit. [Read more |
Read the article in: Science]
TPCB Student John Zinder Uses Click Chemistry to Capture Nuclear RNA Exosome Structure
RNA decay is an essential cellular process that is catalyzed in part by the RNA exosome, a multi-subunit exoribonuclease complex that degrades RNA in the 3´-to-5´ direction. In a recent paper in Molecular Cell, TPCB student John Zinder and colleagues in the lab of Prof. Christopher Lima at Sloan Kettering describe the first high-resolution crystal structure of an 11-subunit nuclear RNA exosome. The team leveraged alkyne–azide click chemistry to synthesize an engineered RNA having two 3´-ends designed to bind concurrently to two exoribonuclease active sites, one in Rrp6 and one in Rrp44. The crystal structure offers valuable information on the way the RNA substrate is routed through the nuclear exosome complex. [Read the article in: Mol. Cell]
Yueming Li Elected Fellow of the American Association for the Advancement of Science
TPCB faculty member Prof. Yueming Li at Sloan Kettering has been elected a Fellow of the American Association for the Advancement of Science. This honorific recognizes AAAS members whose efforts on behalf of the advancement of science or its applications in service to society have distinguished them among their peers and colleagues. Prof. Li is a leader in studying the function, regulation, and inhibition of intramembrane proteases, the most prominent of which is γ-secretase, the enzyme implicated in Alzheimer’s disease. He began his career at Merck Research Laboratories in 1997 where he led the team that discovered presenillin as the catalytic subunit of γ-secretase. He joined the Sloan Kettering and the TPCB faculty in 2002, where his lab has continued to elucidate the components of the γ-secretase complex using biochemical and chemical approaches, reconstituted γ-secretase using recombinant proteins, and studied its functional roles in neurodegenerative disorders and cancer. [Read more]
Sebastian Klinge Receives $1.5M NIH New Innovator Award
Prof. Sebastian Klinge at Rockefeller has been awarded a prestigious Director’s New Innovator grant by the NIH. This $1.5 million, five-year grant will support his lab’s research into assembly of the eukaryotic ribosome. Ribosomes are essential molecular machines that catalyze protein synthesis in cells. The lab’s research focuses on elucidating both the structural anatomy of the ribosome assembly machinery as well as the underlying biochemical transformations involved in the assembly process. Prof. Klinge joined the Rockefeller faculty as an Assistant Professor in 2013 and joined the TPCB faculty shortly thereafter. He is the seventh TPCB faculty member to have received NIH Director’s New Innovator Award since the program’s inception in 2007. [Read more at: Rockefeller | NIH]
TPCB Student Zhen Chen Identify Chemical Probes of Eukaryotic Ribosome Biogenesis
Ribosomes, the complex protein-building machinery of the cell, are assembled at a rate of about 2,000 per minute. However, a lack of suitable chemical probes has made it difficult to decipher the mechanisms underlying this dynamic and essential process in eukaryotes. In a new Cell paper, TPCB student Zhen Chen and colleagues in the lab of Prof. Tarun Kapoor at Rockefeller, describe novel small-molecule probes of ribosome assembly. The Kapoor lab employed chemical and genetic approaches to identify the ribozinoindoles (Rbins) as potent, reversible, cell-permeable inhibitors of eukaryotic ribosome biogenesis. Chemical synthetic lethal screening of a >10,000 compound library in fission yeast revealed ribozinoindole-1 (Rbin-1) to be selectively toxic to cells possessing point mutations in mdn1, an essential gene required for eukaryotic ribosome biogenesis. Several different point mutations in mdn1 were found to confer chemotype-specific resistance to Rbin-1 in cells. Biochemical studies revealed direct inhibition of the ATPase activity of Mdn1 by Rbin-1. Furthermore, the same mutation that protected cells from Rbin-1 also suppressed inhibition of enzyme activity in vitro. In cell-based studies, the group used Rbins to acutely inhibit or activate Midasin function and discovered that Midasin plays multiple roles in assembling precursors of the 60S subunit. In addition to their value as chemical probes of ribosome biogenesis, the Rbins could form the basis for new drugs to treat fungal infections through a novel mechanism of action.
Bachovchin Lab Identifies New Mechanistic Pathway in Cancer Immunotherapy
Cancer immunotherapies, drugs that induce the immune system to attack tumor cells, show great promise in the clinic. However, limitations associated with existing therapies create the impetus to explore new immunotherapeutic mechanisms. Reporting in Nature Chemical Biology, Prof. Daniel Bachovchin and his group at Sloan Kettering, which includes TPCB students Darren Johnson, Eun Bin Go, and Ashley Chui, describe a small molecule that stimulates an immune response against cancer through an unusual mechanism called pyroptosis. Pyroptosis is a form of immune cell death wherein the cell swells, bursts, and releases pro-inflammatory signaling molecules into the environment, which then triggers an immune response. The small molecule Val-boroPro, originally designed to inhibit the serine protease DPP4, is known to induce persistent tumor immunity in mice. However, the mechanism of this immunoresponse had remained a mystery. The Bachovchin lab used activity-based protein profiling to test Val-boroPro for inhibition of ≈100 recombinant serine hydrolases in biochemical assays. They discovered that the molecule potently inhibits DPP8 and DPP9 and that inhibition of these two serine proteases leads to direct activation of pro-caspase-1. The activated pro-protein fails to self-cleave to mature caspase-1 and instead cleaves and activates gasdermin D, leading to induction of pyroptosis in two types of immune cells. Val-boroPro is the first small molecule known to induce an immunoresponse through pyroptosis. Further studies into this immune response mechanism could lead to a new class of cancer immunotherapeutics. [Read more | Read the article in: Nat. Chem. Biol.]
Luciano Marraffini Named HHMI-Simons Faculty Scholar
TPCB faculty member Prof. Luciano Marraffini at Rockefeller has been named a Howard Hughes Medical Institute Faculty Scholar. This new program supports early-career scientists who have great potential to make unique contributions to their fields and was established recently by HHMI, The Simons Foundation, and The Bill & Melinda Gates Foundation. Prof. Marraffini’s lab studies the fundamental mechanisms behind CRISPR-based immunity in bacteria and other microorganisms. The system enables the bacteria to remember the DNA sequences of invading phages, so they can cleave viral DNA upon subsequent infections. In 2008, while a postdoc at Northwestern University, Dr. Marraffini demonstrated that CRISPR immunity targets the DNA of the invader, rather than the RNA as previously thought. More recently, his lab at Rockefeller has gained important insights into the roles of the enzyme Cas9 in acquisition and implementation of this immunity, as well as our understanding of how bacteria distinguish between harmful and beneficial viruses. Prof. Marraffini joined the Rockefeller faculty in 2010 and was promoted to Associate Professor earlier this year. [Read more at: Rockefeller | HHMI]
Yael David, Richard Hite, and Pengbo Zhou Hoin the TPCB Faculty
TPCB recently welcomed three new faculty members to the program, bringing diverse research interests in chemical epigenetics, ion channel structure, and protein degradation.
• Prof. Yael David of Memorial Sloan Kettering is using a novel semisynthetic approach to generate histone proteins bearing specific post-translational modifications that impact chromatin remodeling. Her lab is interested in probing the roles and regulation of these epigenetic modifications in cancer biology and neuroscience. She received her PhD in 2011 from The Weizmann Institute under the guidance of Prof. Ami Navon. From 2011–2016, she carried out postdoctoral training in Prof. Tom Muir’s lab at Princeton. Prof. David joined TPCB and the MSK faculty in September 2016. [Read more]
• Prof. Richard Hite of Memorial Sloan Kettering is interested in studying the structures and functions of lysosomal cation channels that regulate lysosomal trafficking, fusion, and catabolite efflux. His lab leverages expertise in cryo-electron microscopy, X-ray crystallography, biochemistry, and biophysics to elucidate mechanisms of gating and selectivity in these channels. He carried out his PhD studies with Prof. Thomas Walz at Harvard, graduating in 2010. He then joined Prof. Rod MacKinnon’s lab at Rockefeller for his postdoctoral training from 2011–2016. Prof. Hite joined TPCB and the MSK faculty in September 2016. [Read more]
• Prof. Pengbo Zhou of Weill Cornell studies the molecular mechanisms by which ubiquitin-dependent proteolysis operates under physiological conditions and how dysregulation of the ubiqutin-proteasome pathway contributes to cancer and neurological diseases. His lab uses a combination of chemical, biochemical, cell and molecular biological, and mouse genetic approaches to study the Cullin family of ubiquitin ligases as potential anticancer drug targets. Prof. Zhou has been a member of the Weill Cornell faculty since 1999. [Read more]
Chemical Biology Shines at the 12th Annual Tri-Institutional Symposium
TPCB hosted the 12th Annual Chemical Biology Symposium on August 17, 2016 at MSK. The student-organized event was attended by over 180 undergraduates, graduate students, postdocs, staff scientists, and faculty, and included seminars by emminent faculty keynote speakers and TPCB students, and a vibrant poster session highlighting chemical biology research across the Tri-Institutional Research Program. Prof. Matthew Shair from Harvard kicked off the day with an enthralling presentation of his lab’s work using small-molecule inhibitors based on the natural product cortistatin to study the role of Mediator complex kinases in leukemia. TPCB student Adam Levinson, from the lab of Prof. Samuel Danishefsky, then presented his impressive total synthesis of the D-enantiomer of the K-Ras oncoprotein for inhibitor discovery using mirror image phage display. Prof. Ming Hammond from Berkeley shared her lab’s exciting research on riboswitch-based approaches to studying bacterial and immune signaling. TPCB student Malik Chaker-Margot closed out the morning session with his seminal work illuminating stage-specific assembly of processome proteins involved in maturation of the eukaryotic ribosome.
Symposium participants then enjoyed lunch and a poster session featuring the latest research advances from chemical biology students, staff, and faculty from labs across the entire Tri-Institutional Research Program. Poster awards went to Zhen Chen (Kapoor Lab, RU), Alexis Jaramillo (Darst Lab, RU), John Zinder (Lima Lab, MSK), and Matthew Streeter (David Spiegel Lab, Yale University). In the afternoon, TPCB faculty member Prof. Scott Blanchard of Weill Cornell presented his lab’s exciting new work on single-molecule imaging of integral membrane proteins. TPCB student Rudolf Píša followed by sharing his work in the lab of Prof. Tarun Kapoor at Rockefeller to develop selective small-molecule inhibitors of AAA+ enzymes. Finally, Prof. Laura Kiessling from the University of Wisconsin-Madison spoke about her lab’s intriguing recent discovery of selective microbial carbohydrate binding by the human intelectin-1 protein. The day concluded with a reception at which students, postdocs, and faculty continued to discuss the latest exciting advances in chemical biology. The event was co-chaired by TPCB students Michaelyn Lux (Tan Lab, MSK) and Jacob Litke (Jaffrey Lab, Weill Cornell), with support from TPCB faculty mentor Prof. Daniel Heller (MSK), and received generous promotional and poster prize support from ACS Chemical Biology, Nature Chemical Biology, the Royal Society of Chemistry, and the New York Academy of Sciences.
Lewis Cantley and Neal Rosen Named NCI Outstanding Investigators
TPCB faculty members Prof. Lewis Cantley at Weill Cornell and Prof. Neal Rosen at Sloan Kettering have received Outstanding Investigator Awards from the National Cancer Institute. These prestigious grants were established in 2015 to support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The $4.2M award provides long-term support over a seven-year period and is intended to allow investigators the opportunity to take greater risks and be more adventurous in their research. [Read more]
Prof. Cantley’s research focuses on studying the biochemical pathways by which oncogenes mediate changes in cellular metabolism, growth, and transformation. His lab discovered the phosphoinositide 3-kinase (PI3K) enzymes in 1984 and has found that the PI3K pathway controls cell growth primarily through regulation of cellular metabolism. His lab is now investigating drug combinations with PI3K inhibitors that are likely to be more effective than single inhibitors. They are also developing small-molecule inhibitors of phosphatidylinositol-5-phosphate 4-kinases to investigate the cellular functions of these enzymes and their potential as new therapeutic targets. Prof. Cantley began his career at Harvard and Tufts and joined Weill Cornell and the TPCB faculty in 2012. [Read more]
Prof. Rosen’s lab studies signal transduction pathways that cause dysregulation of growth and inhibition of apoptosis in advanced human cancers. His current research focuses on understanding the roles of feedback inhibition by oncoproteins in both physiologic and oncogenic signaling. This work has critical implications for the use of small molecule anticancer drugs that inhibit oncoprotein-activated signaling but concurrently reactivate physiologic signaling pathways and promises to enable the development of rational combination therapies that target these reactivated pathways. Prof. Rosen began his career at the NCI and joined the Sloan Kettering faculty in 1992. He has been a TPCB faculty member since the program’s inception in 2001. [Read more]
TPCB Student Hala Iqbal Develops New Platform for Metagenomic Natural Product Discovery
Bacteria have historically served as a rich source of novel natural products with diverse biological activities, including many clinically used drugs. However, the vast majority of bacteria cannot be cultured in the lab, so identifying natural products from these bacteria requires development of methods for heterologous expression of the underlying biosynthetic genes from metagenomic sources such as soil samples. To address this problem, recent TPCB graduate Hala Iqbal, PhD and Prof. Sean Brady at Rockefeller have screened a collection of 39 strains of Streptomyces bacteria for their ability to support heterologous expression of natural product biosynthetic pathways. Streptomyces are well known to produce diverse natural products native to the individual strains, but have thus far been of limited utility for heterologous expression. They identified Streptomyces albus as the most effective heterologous host, then used it to screen over one million metagenomic DNA cosmids. This led to the discovery of a novel tricyclic natural product, which they named metatricycloene. This new heterologous expression platform should now facilitate discovery of other natural products with novel structures and biological activities. [Read the article in: J. Am. Chem. Soc.]
TPCB Graduate Amrita Hazra Launches Her Independent Lab at IISER-Pune
Congratulations to TPCB alumna Amrita Hazra, PhD who recently joined the Indian Institute of Science Education and Research (IISER), Pune as an Assistant Professor in Chemistry & Biology. Prof. Hazra’s lab investigates the genetic pathways and molecular and enzymatic mechanisms involved in microbial metabolism. [Read more]
She joins four other TPCB alumni in tenure-track faculty positions:
• Jarrod French, PhD (Assistant Professor, Department of Biochemistry & Cell Biology, Stony Brook University) studies the structure, function, and control of enzymes and enzyme complexes involved in cellular metabolism. [Read more]
• Niroshika Keppetipola, PhD (Assistant Professor, Department of Chemistry & Biochemistry, California State University Fullerton) explores how posttranslational modifications alter the activity of splicing factors and, in turn, cellular gene expression. [Read more]
• Jayakrishnan Nandakumar, PhD (Assistant Professor, Department of Molecular, Cellular, & Developmental Biology, University of Michigan) investigates how telomeres and telomerase participate in cancer, stem cell fitness, aging, and genome stability. [Read more]
• Brian Zoltowski, PhD (Assistant Professor, Department of Chemistry, Southern Methodist University) studies the molecular mechanisms of blue-light photoreceptors. [Read more]
TPCB’s over 60 PhD alumni have used their training in chemical biology to pursue research careers in universities, major pharmaceutical companies, biotechnology firms, research institutes, and government labs, and to take up leading positions in science policy, outreach, education, consulting, and patent law. [Read more]
TPCB Congratulates Our 2016 Graduates
Congratulations to the TPCB’s 2016 graduates Debjani Chakraborty (Brady Lab, Rockefeller), Stefanie Gerstberger (Tuschl Lab, Rockefeller), Han Guo (Luo Lab, Sloan Kettering), David Iaea (Maxfield Lab, Weill Cornell), Hala Iqbal (Brady Lab, Rockefeller), Thinh Nguyen Duc (Huse Lab, Sloan Kettering), Xiaoqiu Yuan (Hang Lab, Rockefeller), Qinsi Zheng (Blanchard Lab, Weill Cornell). Our graduates received their degrees at the Weill Cornell Graduate School of Medical Sciences graduation ceremony on May 25, 2016 at Carnegie Hall. Students in Sloan Kettering labs were also recognized at the Gerstner Sloan Kettering Commencement Ceremony on May 19, 2016. Students in Rockefeller labs were recognized at The Rockefeller University Commencement Ceremony on June 9, 2016.
• Debjani Chakraborty, PhD – “Studies towards the Discovery of Novel Natural Products through Functional Analysis of Environmental-DNA Derived Type II Polyketide Synthases”, Postdoctoral Fellow, Prof. Kamlesh Yadav, Mount Sinai
• Stefanie Gerstberger, PhD – “Genome-wide Targeted Approaches to the Study of PTGR and Identification and Characterization of NEF-sp in the 3’ End Maturation of 28S rRNA”, Medical Student, PhD to MD Program, Columbia University
• Han Guo, PhD – “Bioorthogonal Substrate Profiling and Functional Studies of Arginine Methylation”, Business Development Manager, Betta Pharmaceuticals Co., Ltd.
• David Iaea, PhD – “Structure & Function Studies of the Sterol Transport Protein, STARD4”, Associate Scientist, Genentech
• Hala Iqbal, PhD – “Mining Natural Products from Uncultured Bacteria: Functional Screening of Soil Metagenomic Libraries for Antibacterial and Colored Compounds”, Postdoctoral Fellow, Prof. Sean Brady, The Rockefeller University
• Thinh Nguyen Duc, PhD – “Photochemical Approaches to Control Cell Surface Receptors Activation with Spatiotemporal Specificity”, Senior Life Sciences Specialist, L.E.K. Consulting
• Xiaoqiu Yuan, PhD – “Chemical Tools for Exploring IFITM3 S-palmitoylation and Mechanism”, Equity Research Associate, Credit Suisse
• Qinsi Zheng, PhD – ““Self-healing” Organic Fluorophores for Single-molecule Microscopy and Spectroscopy”, Postdoctoral Fellow, Professor Robert Singer, Janelia Research Campus
David Scheinberg Wins Award for Excellence in Teaching and Mentoring
TPCB faculty member Prof. David A. Scheinberg at Sloan Kettering has been awarded the 2016 Excellence in Teaching and Mentoring Award by the Weill Cornell Graduate School, in recognition of his exceptional efforts in mentoring both graduate students and junior faculty during his 26 years on the faculty. Since joining the WCGS faculty in 1990, Prof. Scheinberg has trained 24 PhD graduate students and 34 postdoctoral fellows, many of whom have gone onto successful careers in academia and industry. Prof. Scheinberg was nominated by former trainees who cited his steadfast support, scientific creativity, and collaborative spirit as critical to their success in tackling challenging new problems in chemical biology and biomedical research. This award also recognizes Prof. Scheinberg’s efforts over the last 15 years to recruit and mentor junior faculty, including current TPCB faculty members Prof. Derek Tan, Prof. Yueming Li, Prof. Gabriela Chiosis, Prof. Minkui Luo, Prof. Alex Kentsis, and Prof. Daniel Heller. In this role, he was instrumental in building the chemical biology research program at MSK.
Prof. Scheinberg received his AB from Cornell University and completed his MD-PhD training at Johns Hopkins. He then carried out his internship and residency at Weill Cornell, then continued onto a fellowship in oncology-pharmacology at MSK. He joined the faculty in 1989 was promoted through the ranks to Member at MSK and Professor at Weill Cornell in 1999. He served as Chairman of the MSK Molecular Pharmacology & Chemistry Program from 2001–2015 and is currently Chairman of the Molecular Pharmacology Program. Prof. Scheinberg has also co-chaired the WCGS Pharmacology graduate program since 1990 with Prof. Lorraine Gudas of Weill Cornell, also a TPCB faculty member. [Read more]
Kentsis Lab Research Program Featured on Humans of New York
TPCB faculty member Prof. Alex Kentsis and his lab’s research program has been featured by Humans of New York for his important work in pediatric cancer research. Prof. Kentsis notes that advances in understanding the molecular basis for cancers are leading to new opportunities for therapy. His research program in chemical biology uses next-generation proteomic approaches to investigate the mechanisms by which genomes and proteomes of tumors are disorganized and to use this information to develop rational cancer therapies. Humans of New York was created by photojournalist Brandon Stanton in 2010 to feature photographs and interviews collected on the streets of New York City. Prof. Kentsis’s lab was featured as part of a Humans of New York fundraising campaign for pediatric cancer research at MSK that raised over $3.8 million in one month, from over 100,000 individuals. [Read more]
NYAS 2016 Chemical Biology Symposium Focuses on Chemical Approches to Epigenetics
TPCB partnered with the New York Academy of Sciences to present the annual year-end NYAS Chemical Biology Symposium on May 25, 2016. The meeting is part of the NYAS Chemical Biology Discussion Group series, which brings together numerous chemical biology laboratories from the greater NYC area to promote collaborations and exchanges of ideas. This year’s symposium featured two keynote speakers Prof. Philip A. Cole of Johns Hopkins and Dr. Kenneth W. Duncan of Epizyme. Prof. Cole spoke about his work using chemical approaches to study acetylation and methylation of protein lysine residues. Dr. Duncan presented Epizyme’s work to develop novel small-molecule anticancer drugs that target methyltransferase enzymes. Numerous students and postdoctoral fellows from participating NYC-area institutions presented talks and posters, including several from TPCB labs. [Read more]
Lewis Cantley Awarded 2016 Wolf Prize in Medicine for Discovery of PI3K
TPCB faculty member Prof. Lewis Cantley of Weill Cornell has been awarded the 2016 Wolf Prize in Medicine by the Wolf Foundation. Prof. Cantley is recognized for his groundbreaking discovery of the enzyme phosphoinositide-3-kinase (PI3K) and the signaling pathway that it controls. PI3K is aberrantly activated in various cancers and the first drug targeting this enzyme, idelalisib, was recently approved for the treatment of chronic lymphocytic leukemia. Prof. Cantley will share the award with Prof. C. Ronald Kahn of Harvard Medical School, with whom he has collaborated to elucidate links between insulin, PI3K, and diabetes. Prof. Cantley is also the Director of the Sandra and Edward Meyer Cancer Center. [Read more]
Angelica Ferguson and Scott Blanchard Probe Structural Dynamics in Ribosomal Translation
Protein translation requires carefully orchestrated motions of tRNAs through the ribosome active site. To probe these events in real time, TPCB student Angelica Ferguson and TPCB faculty member Prof. Scott Blanchard at Weill Cornell have used state-of-the-art, single-molecule fluorescence imaging approaches to monitor conformational transitions of tRNAs during protein translation. By labeling three individual tRNAs with distinct fluorescent dyes, they used FRET (Förster resonance energy transfer) imaging to measure distance changes between the tRNAs during single-turnover and processive translation reactions. This revealed hidden sub-states of tRNA motions that are stabilized by ribosome-targeting small-molecule antibiotics, providing new insights into the molecular mechanisms of action of these compounds. They also discovered long-range allosteric interactions between spatially separated tRNA binding sites, shedding new light on how conformational dynamics can regulate processive translation. This platform will be invaluable for future studies into the impacts of various protein factors and small-molecule inhibitors on ribosome dynamics. [Read the article in: Mol. Cell]
Gabriela Chiosis, Tarun Kapoor, and Derek Tan Quoted as Voices of Chemical Biology
As part of its 10th anniversary, Nature Chemical Biology asked leading chemical biologists for their views on a variety of issues pertinent to the field. Three TPCB faculty members were quoted during the series, which appeared throughout 2015. Prof. Gabriela Chiosis of Sloan Kettering offered her definition of chemical biology in the June issue, her views on the most important contributions of the field in the July issue, and her advice to young chemical biologists in the November issue. Prof. Tarun Kapoor of Rockefeller and Prof. Derek Tan of Sloan Kettering both shared their thoughts on what they valued most about being part of the chemical biology community in the October issue. Prof. Tan also cited effective communication between chemists and biologists as one of the most significant challenges in the field in the August issue. [Read the articles in Nat. Chem. Biol.: June | July | August | October | November]
Malik Chaker-Margot and Sebastian Klinge Probe Ribosome Assembly Machinery
The ribosome is a complex molecular machine that is comprised of 79 proteins and four rRNA components in eukaryotes. Ribosome assembly is an elaborate process that occurs while the pre-rRNA precursor is being transcribed. The earliest part of this process is carefully coordinated by the ‘small-subunit processome’, a complex of some 70 proteins, many of whose functions are unknown. To determine the temporal order in which small-subunit processome components associate with pre-rRNA at various stages of its transcription, TPCB student Malik Chaker-Margot and TPCB faculty member Prof. Sebastian Klinge at Rockefeller have developed a novel chemical biology approach involving affinity purification of complexes formed on truncated pre-rRNAs of various lengths. They then used mass spectrometry to identify the proteins associated with each truncated pre-rRNA, leading them to propose a revised model for early eukaryotic ribosome assembly involving consecutive recruitment of small-subunit processome components on pre-rRNA domains. This work provides fundamental insights into ribosome assembly and may one day lead to new therapies for rare human disorders that arise from defects in this process. [Read more | Read the article in: Nat. Struct. Mol. Biol. | Read highlight in: Nat. Struct. Mol. Biol.]
Nikola Pavletich Elected to National Academy of Medicine
TPCB faculty member Prof. Nikola Pavletich at Sloan Kettering has been elected to the National Academy of Medicine, formerly the Institute of Medicine of the National Academies. Membership in the Academy is one of the highest honors in the fields of health and medicine and recognizes individuals for outstanding professional achievement and commitment to service. Prof. Pavletich is a leading structural biologist whose work focuses on X-ray crystallographic and biochemical studies of proteins that play key roles in pathways altered in cancer, including the DNA damage response and cell cycle. He joins TCPB faculty member Prof. Lewis Cantley of Weill Cornell, who was elected to the Academy last year. Prof. Pavletich is also Chairman of the Structural Biology Program at Sloan Kettering and has been a Howard Hughes Medical Institute Investigator since 1997. [Read more at: National Academy of Medicine | The Cancer Letter | The ASCO Post]
Kapoor and Chait Labs Shed Light on Fundamental Process of DNA Repair
TPCB faculty members Prof. Tarun Kapoor and Prof. Brian Chait, both at Rockefeller, have collaborated to gain new molecular insights into the recruitment of DNA repair proteins to damaged sites on chromosomes. Using a quantitative chemical proteomic method that the team first reported in 2012, involving photochemical cross-linking, they discovered that a DNA repair protein known as 53BP1 interacts with phosphorylated histone H2AX, a post-translational modification that occurs in response to DNA damage. Such findings are vital to our understanding of disease etiology and may aid in the development of drugs that target DNA repair. [Read more | Read the article in: Nat. Chem. Biol.]
Derek Tan Featured in CUNY “Science Forward” Video Series
Prof. Derek Tan, TPCB Director and faculty member at Sloan Kettering, is one of the scientists featured in the “Science Forward” video series produced by the Macaulay Honors College at the City University of New York (CUNY). In the video on “Drug Development and Discovery”, Prof. Tan talks about the wide range of skills and approaches chemical biologists use to design and synthesize new potential drugs. Viewers can catch a glimpse of Prof. Tan’s lab as well as TPCB student Michaelyn Lux in action. In the final video series, “Scientific Uncertainty”, Prof. Tan is quoted on the exciting role of uncertainty in his research. [View the videos]
TPCB Symposium Highlights Chemical Biology Research Across Tri-Institutional Program
TPCB hosted the 11th Annual Chemical Biology Symposium on August 28, 2015 at MSK, bringing together chemical biology students and faculty from across the Tri-Institutional Research Program and other institutions in New York City. The program featured four distinguished keynote speakers: Prof. Catherine L. Drennan from MIT, Prof. Sarah E. Reisman from Caltech, Prof. Peter G. Schultz from Scripps, and TPCB faculty member Prof. Morgan Huse from MSK. TPCB students Angelica Ferguson (Blanchard Lab, Weill Cornell), Adam Trotta (Danishefsky Lab, MSK), and Stefanie Gerstberger (Tuschl Lab, Rockefeller) also gave oral presentations on their thesis research. The event featured posters from over 30 students and postdocs from across the Tri-Institutional Research Program, with Best Poster Awards given to John Zinder (Lima Lab, MSK), David Iaea (Maxfield Lab), Weill Cornell, and Alexis Jaramillo (Darst Lab, RU).
Daniel Bachovchin, Steven Gross, Xuejun Jiang, and Shixin Liu Join the TPCB Faculty
TPCB recently welcomed four new faculty members to the program, bringing diverse research interests in serine proteases, metabolomics, cell death, and gene regulation.
• Prof. Daniel Bachovchin of Memorial Sloan Kettering is interested in characterizing the roles that serine proteases play in cancer and immune system signaling using activity-based protein profiling, chemical probes, and genome engineering. He received his PhD in 2011 from The Scripps Research Institute under the guidance of Prof. Benjamin F. Cravatt. From 2011–2015, he was a postdoctoral fellow in Prof. Todd Golub’s laboratory at The Broad Institute. Prof. Bachovchin joined TPCB and the Sloan Kettering faculty in September 2015. [Read more]
• Prof. Steven Gross of Weill Cornell Cornell is a leader in the use of mass spectrometry for the analysis of complex biological samples and has had a long-standing research focus on defining the mechanisms of cell signaling by nitric oxide. Most recently, he has established an untargeted metabolite profiling (aka metabolomics) platform to elucidate the broad consequences of genetic and chemical perturbations in vivo. Prof. Gross is an NIH MERIT Awardee and has been a member of the Weill Cornell faculty since 1988. [Read more]
• Prof. Xuejun Jiang of Memorial Sloan Kettering is a leader in studying the molecular basis of critical cellular processes involved in programmed cell death, autophagy, and regulation of tumor suppressors. His lab uses chemical genetic approaches to study new potential therapeutic targets and develops new small molecule inhibitors of those targets. Prof. Jiang has been a member of the Memorial Sloan Kettering faculty since 2003. [Read more]
• Prof. Shixin Liu of Rockefeller is a a biophysicist who studies the interaction, cooperation, and competition among molecular machines involved in gene regulation at the single-molecule level and genome wide. He completed his PhD in chemistry at Harvard in 2009, working with Prof. Xiaowei Zhuang, and has carried out his postdoctoral studies at UC Berkeley with Prof. Carlos Bustamante. Prof. Liu will join TPCB and establish the Laboratory of Nanoscale Biophysics and Biochemistry at Rockefeller in January 2016. [Read more]
TPCB Welcomes Incoming Class of 2015
TPCB welcomed eleven new students to the program: Ashley Chui (Cal State Fullerton), Hatice Didar Ciftci (Boğaziçi University), Emma Garst (Mount Holyoke College), Eun Bin Go (Harvey Mudd College), Darren Johnson (Townson University), Jonghan Lee (Hong Kong University), Rachel Leicher (Wesleyan University), Fangyu Liu (McGill University), Linamarie Miller (Williams College), Nikita Petukhov (Rice University), and Zheng Ser (Cornell University). Our new students represent diverse backgrounds and research interests in chemical biology and have started their first laboratory rotations.
Olga Boudker Named HHMI Investigator
TPCB faculty member Prof. Olga Boudker of Weill Cornell Medical College has been selected as a Howard Hughes Medical Institute Investigator. She is one of 26 selected in the recent competition from nearly 900 applicants. Prof. Boudker’s laboratory uses structural, biophysical, and protein engineering techniques to understanding the mechanisms of membrane transporters. She joins TPCB’s other five HHMI investigators: Jue Chen, Jonathan Goldberg, Christopher Lima, Roderick MacKinnon, and Nikola Pavletich. [Read more at: Weill Cornell | HHMI]
Adam Levinson Receives Honorable Mention for 2015 Rachele Prize
Congratulations to TPCB student Adam Levinson who received an Honorable Mention for the Julian R. Rachele research paper prize! Established in 1983, the Rachele Prize is the highest award given to students by the Weill Cornell Graduate School and is awarded to a PhD candidate for an original research paper on which the candidate is a major author. Adam was recognized for his sole-author paper describing the total synthesis of the alkaloid natural product aspeverin, published in Organic Letters. He is now working on the total chemical synthesis of the K-Ras protein. Adam completed his BS degree in Chemistry at Emory University and is carrying out his PhD studies with Prof. Samuel Danishefsky at Sloan Kettering. [Read the article in: Org. Lett.]
TPCB Congratulates Our 2015 Graduates
Congratulations to the TPCB’s 2015 graduates Gil Blum (Luo Lab, Sloan Kettering), Ian Bothwell (Luo Lab, Sloan Kettering), Roman Subbotin (Chait Lab, Rockefeller) and He Tian (Sakmar Lab, Rockefeller). Our graduates received their degrees at the Weill Cornell Graduate School of Medical Sciences graduation ceremony on May 28, 2015 at Carnegie Hall. Students in Sloan Kettering labs were also recognized at the Gerstner Sloan Kettering Commencement Ceremony on May 21, 2015. Students in Rockefeller labs will be recognized at The Rockefeller University Commencement Ceremony on June 11, 2015.
• Gil Blum, PhD – “Remodeling SETD8: A Holistic Approach for the Study of Protein Methyl Transferases (PMT’s)”, Postdoctoral Fellow, Prof. Minkui Luo, Sloan Kettering Institute
• Ian Bothwell, PhD – “Development and Application of Chemical Tools for the Study of SAM-Dependent Methyltranferases”, Postdoctoral Fellow, Prof. Wilfred van der Donk, University of Illinois at Urbana Champaign
• Roman Subbotin, PhD – “A Method for Determining Protein-Protein Interactions and Proximities in the Cellular Milieu”, Postdoctoral Fellow, Prof. Brian Chait, The Rockefeller University
• He Tian, PhD – “Development of Novel Chemical Biology Tools for Probing Structure-Function Relationship in G Protein Coupled Receptors”, Postdoctoral Fellow, Prof. Thomas Sakmar, The Rockefeller University
NYAS 2015 Chemical Biology Symposium Brings Together Labs from NYC and Beyond
TPCB partnered once again with the New York Academy of Sciences to present the annual NYAS Chemical Biology Symposium on May 18, 2015. The meeting is presented by the NYAS Chemical Biology Discussion Group, which brings together students, postdocs, and faculty from the NYC area and beyond to discuss the latest research in chemical biology. This year’s symposium featured keynote speaker Prof. Scott J. Miller of Yale University, who presented his lab’s latest work in catalyst development for the selective functionalization of complex molecules. TPCB students also presented their work in a vibrant poster session, alongside colleagues from Columbia, Yale, Princeton, U. Penn, NYU, Stony Brook, Hunter College, Mount Sinai, Albert Einstein College of Medicine, U. Delaware, Rutgers, and Seton Hall. [Read more]
TPCB Founding Leader Joins Weill Cornell Medical College to Advance Cancer Research
Dr. Harold Varmus, co-founder of the TPCB program, joins Weill Cornell Medical College’s faculty as the Lewis Thomas University Professor of Medicine and will collaborate with investigators at the Sandra and Edward Meyer Cancer Center, led by Meyer Director and TPCB faculty member Prof. Lewis C. Cantley. Dr. Varmus was the President of the Memorial Sloan Kettering Cancer Center from 2000–2010 and was instrumental in the founding of the Tri-Institutional Research Program. He most recently Director of the National Cancer Institute until March 2015. Dr. Varmus was awarded the Nobel Prize in Medicine with J. Michael Bishop in 1989 for the discovery of the cellular origin of retroviral oncogenes. [Read more]
Stewart Shuman Elected Fellow of the American Academy of Arts and Sciences
TPCB faculty member Prof. Stewart Shuman at Memorial Sloan Kettering has been elected to the American Academy of Arts and Sciences. Prof. Shuman’s lab has led important research into the evolution and mechanisms of viral and microbial enzymes involved in the metabolism of nucleic acids, including processes such as mRNA synthesis and processing, and DNA repair and recombination. His wide-ranging discoveries have shed light on some of the most basic aspects of molecular biology, including how cells safeguard their genetic material and how genes are regulated. He joins five other TPCB faculty members as Fellows: C. David Allis (2001), Lewis Cantley (1999), Samuel Danishefsky (1984), Dinshaw Patel (2014), and Nikola Pavletich (2014). [Read more]
David Iaea Awarded NIH Fellowship
Congratulations to TPCB student David Iaea, who has been awarded a Ruth Kirschstein Predoctoral Fellowship from the National Institutes of Health! This fellowship will support David’s research on the structure and function of the sterol transport protein STARD4 with TPCB faculty Prof. Fred Maxfield at Weill Cornell. David has a Bachelor’s degree in Biochemistry from New York University and is interested in studying the mechanisms that mediate cholesterol distribution and homeostasis.
Michaelyn Lux and Chaya Stern Awarded NSF Graduate Fellowships
Congratulations to TPCB students Michaelyn Lux and Chaya Stern who have been awarded a National Science Foundation (NSF) Graduate Research Fellowship. They join a select group of 2,000 awardees among 16,500 applicants nationwide. Michaelyn Lux is working with Prof. Derek Tan at Sloan Kettering on the synthesis of novel anticancer agents inspired by natural products. Michaelyn received her Bachelor’s degree in Chemistry from Michigan State University and is interested in studying organic chemistry and its applications to biological problems. Chaya Stern is working with Prof. John Chodera at Sloan Kettering in collaboration with Prof. Harel Weinstein and Prof. Scott Blanchard at Weill Cornell on combining single-molecule experiments with massively distributed molecular dynamics simulations to study G-protein coupled receptor dynamics. Chaya received her Bachelor’s degree in Chemistry from Brooklyn College and is interested in combining theory and experiments within a quantitative and testable framework to study biological macromolecules. [Read more]
Lewis Cantley Wins 2015 Canada Gairdner International Award
TPCB faculty member Prof. Lewis Cantley of Weill Cornell Medical College has won the 2015 Canada Gairdner International Award from the Gairdner Foundation for his groundbreaking discovery of phosphoinositide 3-kinase (PI3K) and the signaling pathway that it controls. The Canada Gairdner International Awards are given annually to five biomedical scientists from around the world whose significant contributions to medicine have increased the understanding of human biology and disease. [Read more]
Minkui Luo Receives 2015 Eli Lilly Award in Biological Chemistry
TPCB faculty member Prof. Minkui Luo of Sloan Kettering has been awarded the 2015 Eli Lilly Award in Biological Chemistry from the American Chemical Society in recognition of his contributions to implement chemical tools to study biologically relevant enzymes. Prof. Luo’s focuses on functional annotation and pharmacological perturbation of protein methyltransferases (PMTs). The award recognizes his accomplishments in developing the novel Bioorthogonal Profiling of Protein Methylation (BPPM) technology to profile proteome-wide/genome-wide methylation events of designated PMTs; and leveraging unconventional strategies to access PMT inhibitors within the scope of PMT perturbation in general and disease therapy in particular. [Read more]
TPCB Faculty Collaboration Reveal New Insights into the Function of Transporters in the Brain
Healthy brain function depends upon communication between neurons carried out by neurotransmitters. After a neuron in the brain communicates with a neighboring neuron by releasing a burst of the neurotransmitter glutamate, those molecules must be cleared away rapidly to shut off the signal and ready cells for the next communication. Impaired glutamate transporter function is linked to neurodegeneration, brain damage following stroke and other disorders. TPCB faculty members Prof. Scott Blanchard and Prof. Olga Boudker and their labs at Weill Cornell have used a combination of single-molecule, X-ray crystallographic, and computational techniques to study glutamate transporters that shuttle this neurotransmitter across the cell membrane. Strikingly, they discovered that the glutamate transporter operates like an elevator, with a large portion of the protein gliding back and forth inside a membrane-embedded scaffold as it shuttles its cargo. This “elevator model” is entirely different from how other transporters were known to function. Their discoveries were made possible through collaborative efforts with Prof. Harel Weinstein at Weill Cornell and Prof. Jack Freed at Cornell University. [Read more| Read the article in: Nature]
John Blenis, Olga Boudker, and Jue Chen Join the TPCB Faculty
TPCB recently welcomed three new faculty members to the program, bringing diverse research interests in chemical cell biology, small-molecule inhibitor discovery, and structure and function of membrane transporter proteins.
• Prof. John Blenis of Weill Cornell is a leader in the field of signal transduction and has helped to define major signaling pathways in cancer, including those involving Ras, PI3K, and mTOR. These studies have identified promising new therapeutic targets and the lab is now pursuing small-molecule screens to develop drug combinations that selectively kill cancer cells. Prior to joining Weill Cornell and TPCB, Prof. Blenis was on the faculty of Harvard Medical School for 25 years. [Read more]
• Prof. Olga Boudker of Weill Cornell has carried out seminal studies of the structure and function of glutamate transporters, which are responsible for the uptake of the neurotransmitter glutamate to enable proper synaptic function. These transporters use gradients of sodium and potassium ions to provide the necessary energy for glutamate transport. The lab uses X-ray crystallography, biochemistry, and biophysics to understand this coupled transport system. Prof. Boudker has been a member of the Weill Cornell faculty since 2005. [Read more]
• Prof. Jue Chen of Rockefeller is a structural biologist who is widely recognized for her studies of ABC transporters, which couple membrane transport of various molecules with ATP hydrolysis. Using X-ray crystallography, she has determined how this chemical energy is converted into mechanical work through a series of conformational changes in the transporter. Prof. Chen began her career at Purdue University in 2002 and was recruited to Rockefeller in 2014. She has also been an HHMI Investigator since 2008. [Read more]
David Allis Wins 2015 Breakthrough Prize for Discovery of Histone Modifications
TPCB faculty member Prof. C. David Allis of Rockefeller has been awarded one of six 2015 Breakthrough Prizes in Life Sciences for his seminal research in epigenetics. Prof. Allis was recognized for his discovery of covalent chemical modifications of histone proteins that package DNA, and the critical roles of these modifications in regulating gene expression. This fundamentally new mechanism for gene regulation has major implications in a variety of human diseases including cancer and opens the door to the development of new therapeutic approaches. Prof. Allis joins Prof. Lewis Cantley of Weill Cornell as the second TPCB faculty member to be honored with this award. In total, six faculty on the Tri-Institutional campuses have received Breakthrough Prizes, which were established in 2013 by technology entrepreneurs including Google’s Sergey Brin, Facebook’s Mark Zuckerberg, and Alibaba’s Jack Ma and are accompanied by cash awards of $3 million. [Read more]
Lewis Cantley Elected to Institute of Medicine
TPCB faculty member Prof. Lewis Cantley at Weill Cornell has been elected to the Institute of Medicine of the National Academies. Membership in the IOM is one of the highest honors bestowed in the fields of health and medicine. Prof. Cantley is a preeminent chemical biologist and cancer researcher who discovered the phosphoinositide 3-kinase (PI3K) signaling pathway. PI3K is the most commonly mutated gene across various cancers and this discovery has led to revolutionary treatments for cancer, diabetes, and autoimmune diseases. His research focuses on understanding the biochemical pathways by which oncogenes mediate changes in cell metabolism, cell growth, and cell transformation. Prof. Cantley joined Weill Cornell and the TPCB faculty in 2012 from Harvard Medical School and is also Director of the Meyer Cancer Center. [Read more]
Marraffini Lab Develops Programmable Antibiotics to Target Bad Bugs
Most antibiotics used clinically are blunt instruments, which kill not only pathogenic bacteria but also commensal bacteria, often with serious side effects. To address this problem, TPCB faculty member Prof. Luciano Marraffini and his lab at Rockefeller have now developed a smarter, ‘programmable’ antibiotic strategy that selectively targets pathogenic bacteria, particularly those carrying genes for antibiotic resistance. In the approach, they engineer the CRISPR-Cas9 system, which bacteria use to defend themselves against viruses, to target specific DNA sequences for cleavage. By targeting bacterial gene sequences known to encode for antibiotic resistance, this approach could address the most life-threatening infections while simultaneously sparing commensal bacteria, thereby avoiding secondary infections such as those caused by Clostridum difficile. The work demonstrated that the antibiotic system could be used to kill resistant Staphylococcus aureus in a mouse skin infection model and was carried out in collaboration with the lab of Rockefeller colleague, Prof. Vincent Fischetti. [Read more | Read the article in: Nat. Biotechnol.]
TPCB Co-Sponsors New York Academy of Sciences Symposium on Click Chemistry
TPCB was proud to co-sponsor the New York Academy of Sciences event, Click Chemistry in Biology and Medicine Symposium: New Developments and Strategies. The symposium was held on September 15, 2014 and explored recent developments in click chemistry, including the discovery of new click reactions. The program included keynote talks by 2001 Nobel Laureate Prof. K. Barry Sharpless and Prof. James Paulson, both of The Scripps Research Institute. Other speakers included Prof. Yimon Aye (Cornell University), Prof. David A. Spiegel (Yale University) and Prof. Peng Wu (Albert Einstein College of Medicine). [Read more]
TPCB Symposium Showcases Forefront Research in Chemical Biology
TPCB hosted its 10th Annual Chemical Biology Symposium on July 18, 2014 at The Rockefeller University with over 100 chemical biology researchers in attendance. The program featured four distinguished keynote speakers: Prof. Raymond Deshaies from the California Institute of Technology, Prof. Kai Johnsson from École Polytechnique Fédérale de Lausanne, Prof. Dorothee Kern from Brandeis University, and TPCB faculty member Prof. Sebastian Klinge from Rockefeller University. TPCB students Ian Bothwell (Luo Lab, Sloan Kettering), Rashad Karimov (Gin/Tan Lab, Sloan Kettering), and Roman Subbotin (Chait Lab, Rockefeller) also presented seminars on their graduate research. Numerous scientists from the broader Tri-Institutional chemical biology community also shared their work at a poster session, with Best Poster Awards going to Gil Blum (Luo Lab, Sloan Kettering), David Iaea (Maxfield Lab, Weill Cornell), Alexis Jaramillo (Nimigean Lab, Weill Cornell), and Dr. Nathan Westcott (Hang Lab, Rockefeller).
Kapoor Lab Develops New Approach to Identify Biological Targets of Small Molecules
Identifying the biological targets of bioactive small molecules is a major challenge in chemical biology and a classical bottleneck in the field. TPCB Faculty Member Prof. Tarun Kapoor and his lab at Rockefeller University have now developed a powerful new approach that enables rapid identification and validation of these targets, using state-of-the-art genome sequencing and editing technologies. The work was carried out through a multidisciplinary collaboration with computational biologist Prof. Olivier Elemento at Weill Cornell Medical College. Their approach involves initial identification of cells that are resistant to the activity of the small molecule, followed by high-throughput transcriptome sequencing to identify the genetic mutations in the cells that confer this resistance. These candidate targets are then validated by using a genome editing technology called the CRISPR-Cas9 system to insert the specific mutated gene into a new cell line and confirm resistance to the small molecule. The method can be used to identify both direct physiological targets of the molecules as well as epigenetic and other indirect resistance mechanisms. The new technology was demonstrated using two anticancer drugs and is called ‘DrugTargetSeqR’. [Read the article in: Nat. Chem. Biol.]
Pavletich and Patel Elected Fellows of the American Academy of Arts and Sciences
TPCB faculty members Prof. Nikola Pavletich and Prof. Dinshaw Patel at Memorial Sloan Kettering have been elected to the American Academy of Arts and Sciences. Prof. Pavletich’s research group is interested in the structural biology of pathways that are altered in cancer, with particular emphasis on pathways that control the growth and proliferation of the cell. Prof. Patel’s lab applies crystallographic and solution NMR techniques to investigate macromolecular-mediated recognition, regulation, and catalysis. They join two other TPCB faculty members as Fellows, Prof. Samuel Danishefsky (1984) and Prof. C. David Allis (2001). [Read more]
NYAS Chemical Biology Symposium Features Local Students and Postdocs
TPCB partnered with the New York Academy of Sciences to present the annual year-end NYAS Chemical Biology Symposium on June 3, 2014. The meeting is a highlight of the NYAS Chemical Biology Discussion Group series, which aims to enhance interactions among local-area laboratories working in chemical biology and to feature forefront research in chemical biology to the wider community. The series traditionally covers a range of current topics in chemical biology, including chemical probe development, organic synthesis, biosynthesis, protein engineering, nanotechnology, and drug discovery. This year’s symposium featured keynote speaker Prof. Brent Stockwell of Columbia University, as well as student talks and posters from participating tri-state area institutions, including several TPCB labs. [Read more]
TPCB Congratulates Our 2014 Graduates
Congratulations to the TPCB’s 2014 graduates Anupam Chakravarty (Shuman Lab, Sloan Kettering), Ushati Das Chakravarty (Shuman Lab, Sloan Kettering), Rashad Karimov (Gin/Tan Lab, Sloan Kettering), and Vidhya Rangaraju (Ryan Lab, Weill Cornell)! The graduates received their degrees at the Weill Cornell Graduate School of Medical Sciences graduation ceremony on May 29, 2014 at Carnegie Hall. Students in Sloan Kettering labs were also recognized at the Sloan Kettering Institute Commencement Ceremony on May 14, 2014.
• Anupam Chakravarty, PhD – “Mechanisms of RNA Damage and Repair”, Postdoctoral Fellow, Prof. Daniel Jarosz, Stanford School of Medicine
• Ushati Das Chakravarty, PhD – “End-healing Mechanisms in DNA and RNA Repair”, Postdoctoral Fellow, Prof. Harry Noller, University of California Santa Cruz
• Rashad Karimov, PhD – “Synthetic Studies on Immunoadjuvant Jujuboside A. Total Synthesis of 23-epi-Jujubogenin”, Postdoctoral Fellow, Prof. John F. Hartwig, University of California, Berkeley
• Vidhya Rangaraju, PhD – “Developing a Novel Quantitative ATP Reporter and Dissecting the Role of ATP in Synaptic Function”, Postdoctoral Fellow, Prof. Erin Schuman, Max Planck Institute for Brain Research
Sebastian Klinge awarded Alfred P. Sloan Research Fellowship
TPCB faculty member Prof. Sebastian Klinge of Rockefeller University was one of 126 scholars nationwide selected to receive an Alfred P. Sloan Research Fellowship. The fellowship supports early-stage scientists pursuing original research. Prof. Klinge will receive $50,000 over two years to further his work on the structure and function of ribosomes, the cell’s protein factories. Three TPCB faculty have been awarded Sloan fellowships previously: Prof. Vanessa Ruta (2013), Prof. Derek Tan (2007), and Prof. Timothy Ryan (1999). [Read more]
Adam Trotta Awarded NSF Graduate Fellowship
Congratulations to TPCB student Adam Trotta, who has been awarded a National Science Foundation (NSF) Graduate Research Fellowship to support his research on synthesis of antibacterial alkaloid natural products with Prof. Samuel Danishefsky at Sloan Kettering! Adam has a Bachelor’s degree in Chemistry from Tufts University and is interested in studying efficient total synthesis of bioactive natural products. He is one of a select group of 2,000 students to receive this honor out of 14,000 applicants nationwide. [Read more]
Tiny Solutions for Big Problems: A Visit to the Lab of Daniel Heller
Chemist and engineer Prof. Daniel Heller, a TPCB faculty member, makes nanoscale materials that are specially designed to enable biological research and solve clinical problems. Using their diverse sets of expertise, members of his lab at Memorial Sloan Kettering work closely together to speed developments in cancer research, diagnosis, and treatment. Team members in the Heller lab are developing carbon nanotube–based sensors to detect early-stage cancers, as well as nanoparticles to target drugs that treat metastatic tumors. [Read more | View video]
Jaffrey Lab Uncovers Mechanism Involved in Fragile X Syndrome
TPCB faculty member Prof. Samie Jaffrey and his lab at Weill Cornell have uncovered the mechanism by which RNA can direct gene silencing involved in fragile X syndrome, a genetic condition that causes intellectual disability and autism. In their paper in Science, they report that an untranslated region of the messenger RNA forms an RNA•DNA duplex with its complementary DNA strand of the fragile X syndrome gene, shutting down production of a protein needed for communication between brain cells. The researchers also discovered that a small molecule that binds this untranslated region of the mRNA can block this gene silencing mechanism in human embryonic stem cells that carry the allele for fragile X syndrome. This suggests that similar therapeutic strategies may be possible for 20 other diseases caused by related gene silencing mechanisms, ranging from mental retardation to multisystem failure. [Read more | Read the article in: Science]
Tim Ryan and Vidhya Rangaraju Discover New Paradigm for ATP Production in Neurons
TPCB student Vidhya Rangaraju and TPCB faculty member Prof. Timothy Ryan at Weill Cornell have used a novel molecular imaging technology to challenge the conventional dogma on energy production in neurons. Scientists have long thought that neurons produce a steady stream of ATP to enable neurotransmission. However, in their latest paper in Cell, the Ryan lab used a quantitative luciferase reporter to monitor presynaptic ATP levels and discovered that ATP is produced on-demand, rather than continuously. This suggests that brain disorders may be caused by mutations or malfunctions in this on-demand circuitry. Further research will be required to see if such ATP deficits occur in diseased states but this research suggests that new therapeutic approaches might be considered to treat neurodegenerative disorders. [Read more | Read the article in: Cell]
Davis Allis Receives 2014 Japan Prize in Life Sciences
TPCB faculty member Prof. C. David Allis of Rockefeller University has been awarded the 2014 Japan Prize in Life Sciences! This prestigious international award is presented to individuals whose original and outstanding achievements are scientifically impressive, and have also served to promote peace and prosperity for all mankind. Prof. Allis is a pioneer in the field of epigenetics and is being recognized for his discovery of the chemical modifications on DNA-packaging histone proteins that serve as fundamental regulators of gene expression. Each Japan Prize laureate receives a cash prize of 50 million yen. Congratulations to Prof. Allis and his laboratory! [Read more at: Rockefeller | Japan Prize Foundation]
Danishefsky Lab Completes Total Synthesis of the Glycoprotein Erythropoietin
TPCB faculty member Prof. Samuel Danishefsky of Sloan–Kettering and his team have reported a landmark achievement in Science, bridging the gap between biologics and small-molecule drugs by accomplishing the total chemical synthesis of the glycoprotein erythropoietin (EPO) in a single, pure form. EPO is the hormone that controls the production of red blood cells by a process called erythropoiesis. The ability to generate pure EPO will now enable scientists to make numerous forms of the molecule and allow them to study whether certain variants are better than others at inducing the production of red blood cells, as well as participating in other biological processes. The achievement required major advances in the logic of building oligosaccharides and new strategies for assembling polypetides and proteins in a chemical laboratory rather than in a biological cell. The work had been highlighted in both Science and Nature. [Read the article in: Science | Read highlights in: Science | Nature]
Vanessa Ruta Receives 2013 NIH Directors’ New Innovator Award
TPCB faculty member Prof. Vanessa Ruta of Rockefeller University was one of 41 investigators nationwide selected to receive an NIH Directors’ New Innovator Award. The grant supports early-stage investigators pursuing bold and highly innovative research projects. Dr. Ruta is working on a novel neural tracing technique to map the associative olfactory circuits in the fly brain and to discern how odor associations are encoded by synaptic connections and neural ensembles. Her goal is to use optical imaging, labeling, and electrophysiology to directly visualize how individual synaptic connections between neurons are modified as a consequence of learning and experience. The grant provides $2.45 million in funding over a five-year period. Congratulations to Prof. Ruta and her laboratory! [Read more]
Michael Foley to Lead Tri-Institutional Therapeutics Discovery Institute
Preeminent chemist and entrepreneur, Michael A. Foley, PhD, has been named Director of the new Tri-Institutional Therapeutics Discovery Institute. This innovative partnership of Weill Cornell, Rockefeller, Sloan-Kettering, and Takeda Pharmaceutical Company is aimed at advancing early-stage academic drug discovery and will be housed in the top floor of the new Belfer Research Building at Weill Cornell. Dr. Foley was most recently the Director of the Chemical Biology Platform at the Broad Institute of MIT and Harvard. He is the scientific co-founder of four biotechnology companies, a veteran of the pharmaceutical industry, and has placed 12 drugs into clinical development. [Tri-I TDI | Read more at: Weill Cornell | Rockefeller | Sloan-Kettering]
Aconitine Alkaloid Natural Product Total Synthesis Highlighted
Congratulations to TPCB alumnus Dr. Yuan Shi, whose paper in the Journal of the American Chemical Society describing the first total synthesis of the norditerpenoid alkaloid natural product neofinaconitine has been highlighted in Angewandte Chemie as well as in Synfacts. The work was carried out with Dr. Jeremy Wilmot and Dr. Lars Nordstrøm in the laboratory of the late Prof. David Y. Gin, a TPCB faculty member. [Read the article in: J. Am. Chem. Soc. | Read highlights in: Angew. Chem. Intl. Ed. | Synfacts | Org. Chem. Highlights]
Howard Hang and Minkui Luo Speak at Bioorthogonal Chemistry Symposium
TPCB faculty members Prof. Howard Hang and Prof. Minkui Luo, along with Prof. Joe Fox (University of Delaware) presented their research at the New York Academy of Sciences symposium on “Bioorthogonal Chemistry in Biology and Medicine” on December 11, 2013. The symposium featured a stimulating afternoon of lectures and posters with numerous labs from the NYC area in attendance. [Read more]
Joan Massagué Named Director of Sloan-Kettering Institute
Renowned cancer biologist Joan Massagué, PhD has been named Director of the Sloan-Kettering Institute, succeeding Dr. Thomas J. Kelly. With a research career spanning more than 30 years, Dr. Massagué has been lauded for the originality and importance of his work elucidating the mechanism of action for transforming growth factor-beta (TGF-β) signaling. He joined MSKCC in 1989 as Chair of the Cell Biology Program and was named the inaugural Chair of the Cancer Biology & Genetics Program in 2003. He is a member of the National Academy of Sciences and the Institute of Medicine, and an Investigator at the Howard Hughes Medical Institute. [Read more]
Vidhya Rangaraju Completes Her PhD Thesis on a Novel Optical ATP Reporter
Congratulations to TPCB student, Vidhya Rangaraju, who successfully defended her thesis “Developing a Novel Quantitative ATP Reporter and Dissecting the Role of ATP in Synaptic Function” on November 14, 2013! Vidhya carried out her research in the lab of TPCB faculty member Prof. Timothy Ryan at Weill Cornell, where she developed a novel, genetically-encoded, optical ATP reporter for quantitative dynamic measurements of presynaptic ATP concentrations. Using this reporter, she found that electrical activity causes significant demands on presynaptic ATP levels that are met by activity-driven ATP synthesis. The synaptic vesicle cycle serves as the primary source of this ATP demand, resulting in severe impairment of synapse function when local ATP synthesis is compromised (Rangaraju, V.; Calloway, N.; Ryan, T. A. “Activity-driven local ATP synthesis is required for synaptic function.” Cell 2013, in press). She will now be going onto a postdoctoral fellowship with Prof. Erin Schuman, Director of the Max Planck Institute for Brain Research in Frankfurt, Germany. Herzlichen Glückwunsch, Vidhya!
Tri-Institutional Therapeutics Discovery Institute to Accelerate Drug Development
Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) in partnership with Takeda Pharmaceutical Company. This new, groundbreaking institute is designed to expedite the translation of early-stage drug discoveries into innovative treatments and therapies for patients. The Tri-I TDI has been founded thanks to a generous $15 million gift by Lewis and Ali Sanders and a $5 million gift from Howard and Abby Milstein. [Read more | View video]
TPCB Symposium Features Leading Chemical Biologists
TPCB hosted its 9th Annual Symposium on September 30, 2013 at Sloan-Kettering. The Symposium program featured four distinguished keynote speakers: Prof. Andrew Phillips (Yale University), Prof. Hening Lin (Cornell University), Prof. Chuan He (University of Chicago) and TPCB faculty member Prof. Samie Jaffrey (Weill Cornell Medical College). Current TPCB students Ushati Das and Qinsi Zheng also presented seminars on their research and a lunchtime poster session included numerous participants from the broader Tri-Institutional chemical biology community.
Ushati Das Awarded Hutchinson Fellowship
Congratulations to TPCB student Ushati Das, who received the Dorris J. Hutchison Graduate Fellowship to support her research on the structures and mechanisms of RNA repair enzymes with Prof. Stewart Shuman at Sloan-Kettering! [Read more]
Gary Koretzky Named Dean of Weill Cornell Graduate School of Medical Sciences
One of the world’s leading immunologists, Gary Koretzky, MD, PhD, has been named Dean of the Weill Cornell Graduate School of Medical Sciences and Senior Associate Dean for Research at Weill Cornell Medical College, effective October 1, 2013. He succeeds Dr. David Hajjar and joins Dean Sidney Strickland of Rockefeller University and Dr. Thomas Kelly of Memorial Sloan-Kettering Cancer Center on the Executive Committee of TPCB. Dr. Koretzky has been the Francis C. Wood Professor of Medicine at the University of Pennsylvania School of Medicine and studies the biochemistry of T lymphocyte development. He is a member of the Institute of Medicine and a Fellow of the American Academy of Arts and Sciences. [Read more]
TPCB Welcomes Incoming Class of 2013
TPCB welcomed six new students to the program: Shi Chen (Tsinghua University), Malik Chaker-Margot (University of Montreal), Zachary Hann (University of California, San Diego), Cristina Santarossa (Smith College), Chaya Stern (Brooklyn College), and John Zinder (Cornell University and University of Colorado). These students represent diverse research interests in chemical biology and have started their first laboratory rotations. [Read more]
Christopher Lima Selected as HHMI Investigator
TPCB faculty member Prof. Christopher D. Lima of Sloan-Kettering’s Structural Biology Program has been selected as a Howard Hughes Medical Institute Investigator. He is one of 27 selected in the recent competition from more than 1,200 applicants. Dr. Lima’s laboratory uses structural, biochemical, and functional analyses of macromolecules to understand RNA metabolism and its role in cell growth and disease. Dr. Lima joins TPCB’s three other HHMI investigators: Jonathan Goldberg, Roderick MacKinnon, and Nikola Pavletich, along with HHMI Early Career Scientist Sean Brady. [Read more]